{
    "abstract": "Clostridium difficile infection (CDI) is the principal cause of nosocomial diarrhea and pseudomembranous colitis associated with antibiotic therapy. The pathological effects of CDI are primarily attributed to toxins A (TcdA) and B (TcdB). Adequate toxin-specific antibody responses are associated with asymptomatic carriage, whereas insufficient humoral responses are associated with recurrent CDI. While the data supporting the importance of anti-toxin antibodies are substantial, clarity about the toxin domain specificity of these antibodies is more limited. To investigate this matter, combinations of human mAbs targeting multiple domains of TcdB were assessed using toxin neutralization assays. These data revealed that a combination of mAbs specific to all major toxin domains had improved neutralizing potency when compared to equivalent concentrations of a single mAb or a combination of mAbs against one or two domains. The function and toxin domain binding specificity of serum antibodies elicited by immunization of hamsters with a toxoid vaccine candidate was also assessed. Immunization with a toxoid vaccine candidate provoked toxin neutralizing antibodies specific to multiple domains of both TcdA and TcdB. When assessed in a toxin neutralization assay, polyclonal sera displayed greater activity against elevated concentrations of toxins than equivalent concentrations of individual mAbs. These data suggest a potential benefit of any antibody based therapeutic or prophylactic treatment that targets multiple toxin domains.",
    "bib_entries": {
        "b0005": {
            "authors": [
                {
                    "first": "Daniel A.",
                    "initial": "D.A.",
                    "last": "Leffler"
                },
                {
                    "first": "J. Thomas",
                    "initial": "J.T.",
                    "last": "Lamont"
                }
            ],
            "doi": "10.1056/NEJMra1403772",
            "firstpage": "1539",
            "issn": "00284793",
            "lastpage": "1548",
            "pmid": "25875259",
            "pub_year": 2015,
            "title": "Clostridium difficile infection",
            "volume": "372"
        },
        "b0010": {
            "authors": [
                {
                    "first": "Stefano",
                    "initial": "S.",
                    "last": "Di Bella"
                },
                {
                    "first": "Paolo",
                    "initial": "P.",
                    "last": "Ascenzi"
                },
                {
                    "first": "Steven",
                    "initial": "S.",
                    "last": "Siarakas"
                },
                {
                    "first": "Nicola",
                    "initial": "N.",
                    "last": "Petrosillo"
                },
                {
                    "first": "Alessandra",
                    "initial": "A.",
                    "last": "di Masi"
                }
            ],
            "doi": "10.3390/toxins8050134",
            "issn": "20726651",
            "pmid": "27153087",
            "pub_year": 2016,
            "title": "Clostridium difficile toxins A and B: Insights into pathogenic properties and extraintestinal effects",
            "volume": "8"
        },
        "b0015": {
            "authors": [
                {
                    "first": "Maen",
                    "initial": "M.",
                    "last": "Qa'Dan"
                },
                {
                    "first": "Matthew",
                    "initial": "M.",
                    "last": "Ramsey"
                },
                {
                    "first": "Jeremy",
                    "initial": "J.",
                    "last": "Daniel"
                },
                {
                    "first": "Lea M.",
                    "initial": "L.M.",
                    "last": "Spyres"
                },
                {
                    "first": "Barbara",
                    "initial": "B.",
                    "last": "Safiejko-Mroczka"
                },
                {
                    "first": "William",
                    "initial": "W.",
                    "last": "Ortiz-Leduc"
                },
                {
                    "first": "Jimmy D.",
                    "initial": "J.D.",
                    "last": "Ballard"
                }
            ],
            "doi": "10.1046/j.1462-5822.2002.00201.x",
            "firstpage": "425",
            "issn": "14625814",
            "lastpage": "434",
            "pmid": "12102688",
            "pub_year": 2002,
            "title": "Clostridium difficile toxin B activates dual caspase-dependent and caspase-independent apoptosis in intoxicated cells",
            "volume": "4"
        },
        "b0020": {
            "authors": [
                {
                    "first": "Tor C.",
                    "initial": "T.C.",
                    "last": "Savidge"
                },
                {
                    "first": "Wei Hua",
                    "initial": "W.H.",
                    "last": "Pan"
                },
                {
                    "first": "Paul",
                    "initial": "P.",
                    "last": "Newman"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "O'Brien"
                },
                {
                    "first": "Pauline M.",
                    "initial": "P.M.",
                    "last": "Anton"
                },
                {
                    "first": "Charalabos",
                    "initial": "C.",
                    "last": "Pothoulakis"
                }
            ],
            "doi": "10.1016/S0016-5085(03)00902-8",
            "firstpage": "413",
            "issn": "00165085",
            "lastpage": "420",
            "pmid": "12891543",
            "pub_year": 2003,
            "title": "Clostridium difficile toxin B is an inflammatory enterotoxin in human intestine",
            "volume": "125"
        },
        "b0025": {
            "authors": [
                {
                    "first": "Ralf",
                    "initial": "R.",
                    "last": "Gerhard"
                },
                {
                    "first": "Stefanie",
                    "initial": "S.",
                    "last": "Nottrott"
                },
                {
                    "first": "Janett",
                    "initial": "J.",
                    "last": "Schoentaube"
                },
                {
                    "first": "Helma",
                    "initial": "H.",
                    "last": "Tatge"
                },
                {
                    "first": "Alexandra",
                    "initial": "A.",
                    "last": "Oiling"
                },
                {
                    "first": "Ingo",
                    "initial": "I.",
                    "last": "Just"
                }
            ],
            "doi": "10.1099/jmm.0.47769-0",
            "firstpage": "765",
            "issn": "00222615",
            "lastpage": "770",
            "pmid": "18480335",
            "pub_year": 2008,
            "title": "Glucosylation of Rho GTPases by Clostridium difficile toxin A triggers apoptosis in intestinal epithelial cells",
            "volume": "57"
        },
        "b0030": {
            "authors": [
                {
                    "first": "P. H.",
                    "initial": "P.H.",
                    "last": "Kim"
                },
                {
                    "first": "J. P.",
                    "initial": "J.P.",
                    "last": "Iaconis"
                },
                {
                    "first": "R. D.",
                    "initial": "R.D.",
                    "last": "Rolfe"
                }
            ],
            "firstpage": "2984",
            "issn": "00199567",
            "lastpage": "2992",
            "pmid": "3679541",
            "pub_year": 1987,
            "title": "Immunization of adult hamsters against Clostridium difficile-associated ileocecitis and transfer of protection to infant hamsters",
            "volume": "55"
        },
        "b0035": {
            "authors": [
                {
                    "first": "J. F.",
                    "initial": "J.F.",
                    "last": "Torres"
                },
                {
                    "first": "D. M.",
                    "initial": "D.M.",
                    "last": "Lyerly"
                },
                {
                    "first": "J. E.",
                    "initial": "J.E.",
                    "last": "Hill"
                },
                {
                    "first": "T. P.",
                    "initial": "T.P.",
                    "last": "Monath"
                }
            ],
            "firstpage": "4619",
            "issn": "00199567",
            "lastpage": "4627",
            "pmid": "7591115",
            "pub_year": 1995,
            "title": "Evaluation of formalin-inactivated Clostridium difficile vaccines administered by parenteral and mucosal routes of immunization in hamsters",
            "volume": "63"
        },
        "b0040": {
            "authors": [
                {
                    "first": "John A.",
                    "initial": "J.A.",
                    "last": "Kink"
                },
                {
                    "first": "Jim A.",
                    "initial": "J.A.",
                    "last": "Williams"
                }
            ],
            "firstpage": "2018",
            "issn": "00199567",
            "lastpage": "2025",
            "pmid": "9573084",
            "pub_year": 1998,
            "title": "Antibodies to recombinant Clostridium difficile toxins A and B are an effective treatment and prevent relapse of C. difficile-Associated disease in a hamster model of infection",
            "volume": "66"
        },
        "b0045": {
            "authors": [
                {
                    "first": "Paul J.",
                    "initial": "P.J.",
                    "last": "Giannasca"
                },
                {
                    "first": "Michel",
                    "initial": "M.",
                    "last": "Warny"
                }
            ],
            "doi": "10.1016/j.vaccine.2003.11.030",
            "firstpage": "848",
            "issn": "0264410X",
            "lastpage": "856",
            "pmid": "15040937",
            "pub_year": 2004,
            "title": "Active and passive immunization against Clostridium difficile diarrhea and colitis",
            "volume": "22"
        },
        "b0050": {
            "authors": [
                {
                    "first": "Xingmin",
                    "initial": "X.",
                    "last": "Sun"
                },
                {
                    "first": "Haiying",
                    "initial": "H.",
                    "last": "Wang"
                },
                {
                    "first": "Yongrong",
                    "initial": "Y.",
                    "last": "Zhang"
                },
                {
                    "first": "Kevin",
                    "initial": "K.",
                    "last": "Chen"
                },
                {
                    "first": "Barbara",
                    "initial": "B.",
                    "last": "Davis"
                },
                {
                    "first": "Hanping",
                    "initial": "H.",
                    "last": "Feng"
                }
            ],
            "doi": "10.1128/IAI.01336-10",
            "firstpage": "2856",
            "issn": "00199567",
            "lastpage": "2864",
            "pmid": "21576341",
            "pub_year": 2011,
            "title": "Mouse relapse model of Clostridium difficile infection",
            "volume": "79"
        },
        "b0055": {
            "authors": [
                {
                    "first": "Gregory J.",
                    "initial": "G.J.",
                    "last": "Babcock"
                },
                {
                    "first": "Teresa J.",
                    "initial": "T.J.",
                    "last": "Broering"
                },
                {
                    "first": "Hector J.",
                    "initial": "H.J.",
                    "last": "Hernandez"
                },
                {
                    "first": "Robert B.",
                    "initial": "R.B.",
                    "last": "Mandell"
                },
                {
                    "first": "Katherine",
                    "initial": "K.",
                    "last": "Donahue"
                },
                {
                    "first": "Naomi",
                    "initial": "N.",
                    "last": "Boatright"
                },
                {
                    "first": "Anne M.",
                    "initial": "A.M.",
                    "last": "Stack"
                },
                {
                    "first": "Israel",
                    "initial": "I.",
                    "last": "Lowy"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Graziano"
                },
                {
                    "first": "Deborah",
                    "initial": "D.",
                    "last": "Molrine"
                },
                {
                    "first": "Donna M.",
                    "initial": "D.M.",
                    "last": "Ambrosino"
                },
                {
                    "first": "William D.",
                    "initial": "W.D.",
                    "last": "Thomas"
                }
            ],
            "doi": "10.1128/IAI.00982-06",
            "firstpage": "6339",
            "issn": "00199567",
            "lastpage": "6347",
            "pmid": "16966409",
            "pub_year": 2006,
            "title": "Human monoclonal antibodies directed against toxins A and B prevent Clostridium difficile-induced mortality in hamsters",
            "volume": "74"
        },
        "b0060": {
            "authors": [
                {
                    "first": "Haiying",
                    "initial": "H.",
                    "last": "Wang"
                },
                {
                    "first": "Xingmin",
                    "initial": "X.",
                    "last": "Sun"
                },
                {
                    "first": "Yongrong",
                    "initial": "Y.",
                    "last": "Zhang"
                },
                {
                    "first": "Shan",
                    "initial": "S.",
                    "last": "Li"
                },
                {
                    "first": "Kevin",
                    "initial": "K.",
                    "last": "Chen"
                },
                {
                    "first": "Lianfa",
                    "initial": "L.",
                    "last": "Shi"
                },
                {
                    "first": "Weijia",
                    "initial": "W.",
                    "last": "Nie"
                },
                {
                    "first": "Raj",
                    "initial": "R.",
                    "last": "Kumar"
                },
                {
                    "first": "Saul",
                    "initial": "S.",
                    "last": "Tzipori"
                },
                {
                    "first": "Jufang",
                    "initial": "J.",
                    "last": "Wang"
                },
                {
                    "first": "Tor",
                    "initial": "T.",
                    "last": "Savidge"
                },
                {
                    "first": "Hanping",
                    "initial": "H.",
                    "last": "Feng"
                }
            ],
            "doi": "10.1128/IAI.00215-12",
            "firstpage": "2678",
            "issn": "00199567",
            "lastpage": "2688",
            "pmid": "22615245",
            "pub_year": 2012,
            "title": "A chimeric toxin vaccine protects against primary and recurrent Clostridium difficile infection",
            "volume": "80"
        },
        "b0065": {
            "authors": [
                {
                    "first": "Andre J.",
                    "initial": "A.J.",
                    "last": "Marozsan"
                },
                {
                    "first": "Dangshe",
                    "initial": "D.",
                    "last": "Ma"
                },
                {
                    "first": "Kirsten A.",
                    "initial": "K.A.",
                    "last": "Nagashima"
                },
                {
                    "first": "Brian J.",
                    "initial": "B.J.",
                    "last": "Kennedy"
                },
                {
                    "first": "Yun Kenneth",
                    "initial": "Y.K.",
                    "last": "Kang"
                },
                {
                    "first": "Robert R.",
                    "initial": "R.R.",
                    "last": "Arrigale"
                },
                {
                    "first": "Gerald P.",
                    "initial": "G.P.",
                    "last": "Donovan"
                },
                {
                    "first": "Wells W.",
                    "initial": "W.W.",
                    "last": "Magargal"
                },
                {
                    "first": "Paul J.",
                    "initial": "P.J.",
                    "last": "Maddon"
                },
                {
                    "first": "William C.",
                    "initial": "W.C.",
                    "last": "Olson"
                }
            ],
            "doi": "10.1093/infdis/jis416",
            "firstpage": "706",
            "issn": "00221899",
            "lastpage": "713",
            "pmid": "22732923",
            "pub_year": 2012,
            "title": "Protection against clostridium difficile infection with broadly neutralizing antitoxin monoclonal antibodies",
            "volume": "206"
        },
        "b0070": {
            "authors": [
                {
                    "first": "Lorraine",
                    "initial": "L.",
                    "last": "Kyne"
                },
                {
                    "first": "Michel",
                    "initial": "M.",
                    "last": "Warny"
                },
                {
                    "first": "Amir",
                    "initial": "A.",
                    "last": "Qamar"
                },
                {
                    "first": "Ciar\u00e1n P.",
                    "initial": "C.P.",
                    "last": "Kelly"
                }
            ],
            "doi": "10.1056/NEJM200002103420604",
            "firstpage": "390",
            "issn": "00284793",
            "lastpage": "397",
            "pmid": "10666429",
            "pub_year": 2000,
            "title": "Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A",
            "volume": "342"
        },
        "b0075": {
            "authors": [
                {
                    "first": "Lorraine",
                    "initial": "L.",
                    "last": "Kyne"
                },
                {
                    "first": "Michel",
                    "initial": "M.",
                    "last": "Warny"
                },
                {
                    "first": "Amir",
                    "initial": "A.",
                    "last": "Qamar"
                },
                {
                    "first": "Ciar\u00e1n P.",
                    "initial": "C.P.",
                    "last": "Kelly"
                }
            ],
            "doi": "10.1016/S0140-6736(00)03592-3",
            "firstpage": "189",
            "issn": "01406736",
            "lastpage": "193",
            "pmid": "11213096",
            "pub_year": 2001,
            "title": "Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea",
            "volume": "357"
        },
        "b0080": {
            "authors": [
                {
                    "first": "Brett A.",
                    "initial": "B.A.",
                    "last": "Leav"
                },
                {
                    "first": "Barbra",
                    "initial": "B.",
                    "last": "Blair"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Leney"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Knauber"
                },
                {
                    "first": "Courtney",
                    "initial": "C.",
                    "last": "Reilly"
                },
                {
                    "first": "Israel",
                    "initial": "I.",
                    "last": "Lowy"
                },
                {
                    "first": "Dale N.",
                    "initial": "D.N.",
                    "last": "Gerding"
                },
                {
                    "first": "Ciar\u00e1n P.",
                    "initial": "C.P.",
                    "last": "Kelly"
                },
                {
                    "first": "Kia",
                    "initial": "K.",
                    "last": "Katchar"
                },
                {
                    "first": "Roger",
                    "initial": "R.",
                    "last": "Baxter"
                },
                {
                    "first": "Donna",
                    "initial": "D.",
                    "last": "Ambrosino"
                },
                {
                    "first": "Deborah",
                    "initial": "D.",
                    "last": "Molrine"
                }
            ],
            "doi": "10.1016/j.vaccine.2009.10.144",
            "firstpage": "965",
            "issn": "0264410X",
            "lastpage": "969",
            "pmid": "19941990",
            "pub_year": 2010,
            "title": "Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI)",
            "volume": "28"
        },
        "b0085": {
            "authors": [
                {
                    "first": "B.",
                    "initial": "B.",
                    "last": "Aronsson"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Granstr\u00f6m"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "M\u00f6llby"
                },
                {
                    "first": "C. E.",
                    "initial": "C.E.",
                    "last": "Nord"
                }
            ],
            "doi": "10.1007/BF01642866",
            "firstpage": "97",
            "issn": "03008126",
            "lastpage": "101",
            "pmid": "4030111",
            "pub_year": 1985,
            "title": "Serum antibody response to clostridium difficile toxins in patients with clostridium difficile diarrhoea",
            "volume": "13"
        },
        "b0090": {
            "authors": [
                {
                    "first": "Alfred E.",
                    "initial": "A.E.",
                    "last": "Bacon"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Fekety"
                }
            ],
            "doi": "10.1016/0732-8893(94)90021-3",
            "firstpage": "205",
            "issn": "07328893",
            "lastpage": "209",
            "pmid": "7924215",
            "pub_year": 1994,
            "title": "Immunoglobulin G directed against toxins A and B of Clostridium difficile in the general population and patients with antibiotic-associated diarrhea",
            "volume": "18"
        },
        "b0095": {
            "authors": [
                {
                    "first": "Swati B.",
                    "initial": "S.B.",
                    "last": "Gupta"
                },
                {
                    "first": "Vinay",
                    "initial": "V.",
                    "last": "Mehta"
                },
                {
                    "first": "Erik R.",
                    "initial": "E.R.",
                    "last": "Dubberke"
                },
                {
                    "first": "Xuemei",
                    "initial": "X.",
                    "last": "Zhao"
                },
                {
                    "first": "Mary Beth",
                    "initial": "M.B.",
                    "last": "Dorr"
                },
                {
                    "first": "Dalya",
                    "initial": "D.",
                    "last": "Guris"
                },
                {
                    "first": "Deborah",
                    "initial": "D.",
                    "last": "Molrine"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Leney"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Miller"
                },
                {
                    "first": "Marilyne",
                    "initial": "M.",
                    "last": "Dupin"
                },
                {
                    "first": "T. Christopher",
                    "initial": "T.C.",
                    "last": "Mast"
                }
            ],
            "doi": "10.1093/cid/ciw364",
            "firstpage": "730",
            "issn": "10584838",
            "lastpage": "734",
            "pmid": "27365387",
            "pub_year": 2016,
            "title": "Antibodies to Toxin B Are Protective Against Clostridium difficile Infection Recurrence",
            "volume": "63"
        },
        "b0100": {
            "authors": [
                {
                    "first": "Natalie G.",
                    "initial": "N.G.",
                    "last": "Anosova"
                },
                {
                    "first": "Leah E.",
                    "initial": "L.E.",
                    "last": "Cole"
                },
                {
                    "first": "Lu",
                    "initial": "L.",
                    "last": "Li"
                },
                {
                    "first": "Jinrong",
                    "initial": "J.",
                    "last": "Zhang"
                },
                {
                    "first": "Anna M.",
                    "initial": "A.M.",
                    "last": "Brown"
                },
                {
                    "first": "Sophia",
                    "initial": "S.",
                    "last": "Mundle"
                },
                {
                    "first": "Jianxin",
                    "initial": "J.",
                    "last": "Zhang"
                },
                {
                    "first": "Satyajit",
                    "initial": "S.",
                    "last": "Ray"
                },
                {
                    "first": "Fuqin",
                    "initial": "F.",
                    "last": "Ma"
                },
                {
                    "first": "Pierre",
                    "initial": "P.",
                    "last": "Garrone"
                },
                {
                    "first": "Nicola",
                    "initial": "N.",
                    "last": "Bertraminelli"
                },
                {
                    "first": "Harry",
                    "initial": "H.",
                    "last": "Kleanthous"
                },
                {
                    "first": "Stephen F.",
                    "initial": "S.F.",
                    "last": "Anderson"
                }
            ],
            "doi": "10.1128/CVI.00763-14",
            "firstpage": "711",
            "issn": "15566811",
            "lastpage": "725",
            "pmid": "25924765",
            "pub_year": 2015,
            "title": "A combination of three fully human toxin A- and toxin B-specific monoclonal antibodies protects against challenge with highly virulent epidemic strains of clostridium difficile in the hamster model",
            "volume": "22"
        },
        "b0105": {
            "authors": [
                {
                    "first": "M. H.",
                    "initial": "M.H.",
                    "last": "Wilcox"
                },
                {
                    "first": "D. N.",
                    "initial": "D.N.",
                    "last": "Gerding"
                },
                {
                    "first": "I. R.",
                    "initial": "I.R.",
                    "last": "Poxton"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Kelly"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Nathan"
                },
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Birch"
                },
                {
                    "first": "O. A.",
                    "initial": "O.A.",
                    "last": "Cornely"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "Rahav"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Bouza"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Lee"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "Jenkin"
                },
                {
                    "first": "W.",
                    "initial": "W.",
                    "last": "Jensen"
                },
                {
                    "first": "Y. S.",
                    "initial": "Y.S.",
                    "last": "Kim"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Yoshida"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Gabryelski"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Pedley"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Eves"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Tipping"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Guris"
                },
                {
                    "first": "N.",
                    "initial": "N.",
                    "last": "Kartsonis"
                },
                {
                    "first": "M. B.",
                    "initial": "M.B.",
                    "last": "Dorr"
                },
                {
                    "first": null,
                    "initial": null,
                    "last": null
                }
            ],
            "doi": "10.1056/NEJMoa1602615",
            "firstpage": "305",
            "issn": "00284793",
            "lastpage": "317",
            "pmid": "28121498",
            "pub_year": 2017,
            "title": "Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection",
            "volume": "376"
        },
        "b0110": {
            "authors": [
                {
                    "first": "Alex B.",
                    "initial": "A.B.",
                    "last": "Ryder"
                },
                {
                    "first": "Ying",
                    "initial": "Y.",
                    "last": "Huang"
                },
                {
                    "first": "Haijing",
                    "initial": "H.",
                    "last": "Li"
                },
                {
                    "first": "Min",
                    "initial": "M.",
                    "last": "Zheng"
                },
                {
                    "first": "Xiaobo",
                    "initial": "X.",
                    "last": "Wang"
                },
                {
                    "first": "Charles W.",
                    "initial": "C.W.",
                    "last": "Stratton"
                },
                {
                    "first": "Xiao",
                    "initial": "X.",
                    "last": "Xu"
                },
                {
                    "first": "Yi Wei",
                    "initial": "Y.W.",
                    "last": "Tang"
                }
            ],
            "doi": "10.1128/JCM.01104-10",
            "firstpage": "4129",
            "issn": "00951137",
            "lastpage": "4134",
            "pmid": "20720023",
            "pub_year": 2010,
            "title": "Assessment of Clostridium difficile infections by quantitative detection of tcdB toxin by use of a real-time cell analysis system",
            "volume": "48"
        },
        "b0115": {
            "authors": [
                {
                    "first": "Stephen J.",
                    "initial": "S.J.",
                    "last": "Demarest"
                },
                {
                    "first": "Mangala",
                    "initial": "M.",
                    "last": "Hariharan"
                },
                {
                    "first": "Marikka",
                    "initial": "M.",
                    "last": "Elia"
                },
                {
                    "first": "Jared",
                    "initial": "J.",
                    "last": "Salbato"
                },
                {
                    "first": "Ping",
                    "initial": "P.",
                    "last": "Jin"
                },
                {
                    "first": "Colin",
                    "initial": "C.",
                    "last": "Bird"
                },
                {
                    "first": "Jay M.",
                    "initial": "J.M.",
                    "last": "Short"
                },
                {
                    "first": "Bruce E.",
                    "initial": "B.E.",
                    "last": "Kimmel"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Dudley"
                },
                {
                    "first": "Gary",
                    "initial": "G.",
                    "last": "Woodnutt"
                },
                {
                    "first": "Genevi\u00e8ve",
                    "initial": "G.",
                    "last": "Hansen"
                }
            ],
            "doi": "10.4161/mabs.2.2.11220",
            "firstpage": "190",
            "issn": "19420862",
            "lastpage": "198",
            "pmid": "20150758",
            "pub_year": 2010,
            "title": "Neutralization of Clostridium difficile toxin A using antibody combinations",
            "volume": "2"
        },
        "b0120": {
            "authors": [
                {
                    "first": "Lorraine D.",
                    "initial": "L.D.",
                    "last": "Hernandez"
                },
                {
                    "first": "Heather K.",
                    "initial": "H.K.",
                    "last": "Kroh"
                },
                {
                    "first": "Edward",
                    "initial": "E.",
                    "last": "Hsieh"
                },
                {
                    "first": "Xiaoyu",
                    "initial": "X.",
                    "last": "Yang"
                },
                {
                    "first": "Maribel",
                    "initial": "M.",
                    "last": "Beaumont"
                },
                {
                    "first": "Payal R.",
                    "initial": "P.R.",
                    "last": "Sheth"
                },
                {
                    "first": "Edward",
                    "initial": "E.",
                    "last": "DiNunzio"
                },
                {
                    "first": "Stacey A.",
                    "initial": "S.A.",
                    "last": "Rutherford"
                },
                {
                    "first": "Melanie D.",
                    "initial": "M.D.",
                    "last": "Ohi"
                },
                {
                    "first": "Grigori",
                    "initial": "G.",
                    "last": "Ermakov"
                },
                {
                    "first": "Li",
                    "initial": "L.",
                    "last": "Xiao"
                },
                {
                    "first": "Susan",
                    "initial": "S.",
                    "last": "Secore"
                },
                {
                    "first": "Jerzy",
                    "initial": "J.",
                    "last": "Karczewski"
                },
                {
                    "first": "Fred",
                    "initial": "F.",
                    "last": "Racine"
                },
                {
                    "first": "Todd",
                    "initial": "T.",
                    "last": "Mayhood"
                },
                {
                    "first": "Paul",
                    "initial": "P.",
                    "last": "Fischer"
                },
                {
                    "first": "Xinwei",
                    "initial": "X.",
                    "last": "Sher"
                },
                {
                    "first": "Pulkit",
                    "initial": "P.",
                    "last": "Gupta"
                },
                {
                    "first": "D. Borden",
                    "initial": "D.B.",
                    "last": "Lacy"
                },
                {
                    "first": "Alex G.",
                    "initial": "A.G.",
                    "last": "Therien"
                }
            ],
            "doi": "10.1016/j.jmb.2017.02.010",
            "firstpage": "1030",
            "issn": "00222836",
            "lastpage": "1044",
            "pmid": "28232034",
            "pub_year": 2017,
            "title": "Epitopes and Mechanism of Action of the Clostridium difficile Toxin A-Neutralizing Antibody Actoxumab",
            "volume": "429"
        },
        "b0125": {
            "authors": [
                {
                    "first": "Alexandra",
                    "initial": "A.",
                    "last": "Olling"
                },
                {
                    "first": "Sebastian",
                    "initial": "S.",
                    "last": "Goy"
                },
                {
                    "first": "Florian",
                    "initial": "F.",
                    "last": "Hoffmann"
                },
                {
                    "first": "Helma",
                    "initial": "H.",
                    "last": "Tatge"
                },
                {
                    "first": "Ingo",
                    "initial": "I.",
                    "last": "Just"
                },
                {
                    "first": "Ralf",
                    "initial": "R.",
                    "last": "Gerhard"
                }
            ],
            "doi": "10.1371/journal.pone.0017623",
            "issn": "19326203",
            "pmid": "21445253",
            "pub_year": 2011,
            "title": "The repetitive oligopeptide sequences modulate cytopathic potency but are not crucial for cellular uptake of Clostridium difficile toxin A",
            "volume": "6"
        },
        "b0130": {
            "authors": [
                {
                    "first": "Bj\u00f6rn",
                    "initial": "B.",
                    "last": "Schorch"
                },
                {
                    "first": "Shuo",
                    "initial": "S.",
                    "last": "Song"
                },
                {
                    "first": "Ferdy R.",
                    "initial": "F.R.",
                    "last": "Van Diemen"
                },
                {
                    "first": "Hans H.",
                    "initial": "H.H.",
                    "last": "Bock"
                },
                {
                    "first": "Petra",
                    "initial": "P.",
                    "last": "May"
                },
                {
                    "first": "Joachim",
                    "initial": "J.",
                    "last": "Herz"
                },
                {
                    "first": "Thijn R.",
                    "initial": "T.R.",
                    "last": "Brummelkamp"
                },
                {
                    "first": "Panagiotis",
                    "initial": "P.",
                    "last": "Papatheodorou"
                },
                {
                    "first": "Klaus",
                    "initial": "K.",
                    "last": "Aktories"
                }
            ],
            "doi": "10.1073/pnas.1323790111",
            "firstpage": "6431",
            "issn": "00278424",
            "lastpage": "6436",
            "pmid": "24737893",
            "pub_year": 2014,
            "title": "LRP1 is a receptor for Clostridium perfringens TpeL toxin indicating a two-receptor model of clostridial glycosylating toxins",
            "volume": "111"
        },
        "b0135": {
            "authors": [
                {
                    "first": "K. D.",
                    "initial": "K.D.",
                    "last": "Tucker"
                },
                {
                    "first": "T. D.",
                    "initial": "T.D.",
                    "last": "Wilkins"
                }
            ],
            "firstpage": "73",
            "issn": "00199567",
            "lastpage": "78",
            "pmid": "1670930",
            "pub_year": 1991,
            "title": "Toxin A of Clostridium difficile binds to the human carbohydrate antigens I, X, and Y",
            "volume": "59"
        },
        "b0140": {
            "authors": [
                {
                    "first": "Daniel E.",
                    "initial": "D.E.",
                    "last": "Voth"
                },
                {
                    "first": "Jimmy D.",
                    "initial": "J.D.",
                    "last": "Ballard"
                }
            ],
            "doi": "10.1128/CMR.18.2.247-263.2005",
            "firstpage": "247",
            "issn": "08938512",
            "lastpage": "263",
            "pmid": "15831824",
            "pub_year": 2005,
            "title": "Clostridium difficile toxins: Mechanism of action and role in disease",
            "volume": "18"
        },
        "b0145": {
            "authors": [
                {
                    "first": "Selda",
                    "initial": "S.",
                    "last": "Genisyuerek"
                },
                {
                    "first": "Panagiotis",
                    "initial": "P.",
                    "last": "Papatheodorou"
                },
                {
                    "first": "Gregor",
                    "initial": "G.",
                    "last": "Guttenberg"
                },
                {
                    "first": "Rolf",
                    "initial": "R.",
                    "last": "Schubert"
                },
                {
                    "first": "Roland",
                    "initial": "R.",
                    "last": "Benz"
                },
                {
                    "first": "Klaus",
                    "initial": "K.",
                    "last": "Aktories"
                }
            ],
            "doi": "10.1111/j.1365-2958.2011.07549.x",
            "firstpage": "1643",
            "issn": "0950382X",
            "lastpage": "1654",
            "pmid": "21231971",
            "pub_year": 2011,
            "title": "Structural determinants for membrane insertion, pore formation and translocation of Clostridium difficile toxin B",
            "volume": "79"
        },
        "b0150": {
            "authors": [
                {
                    "first": "Liang",
                    "initial": "L.",
                    "last": "Tao"
                },
                {
                    "first": "Jie",
                    "initial": "J.",
                    "last": "Zhang"
                },
                {
                    "first": "Paul",
                    "initial": "P.",
                    "last": "Meraner"
                },
                {
                    "first": "Alessio",
                    "initial": "A.",
                    "last": "Tovaglieri"
                },
                {
                    "first": "Xiaoqian",
                    "initial": "X.",
                    "last": "Wu"
                },
                {
                    "first": "Ralf",
                    "initial": "R.",
                    "last": "Gerhard"
                },
                {
                    "first": "Xinjun",
                    "initial": "X.",
                    "last": "Zhang"
                },
                {
                    "first": "William B.",
                    "initial": "W.B.",
                    "last": "Stallcup"
                },
                {
                    "first": "Ji",
                    "initial": "J.",
                    "last": "Miao"
                },
                {
                    "first": "Xi",
                    "initial": "X.",
                    "last": "He"
                },
                {
                    "first": "Julian G.",
                    "initial": "J.G.",
                    "last": "Hurdle"
                },
                {
                    "first": "David T.",
                    "initial": "D.T.",
                    "last": "Breault"
                },
                {
                    "first": "Abraham L.",
                    "initial": "A.L.",
                    "last": "Brass"
                },
                {
                    "first": "Min",
                    "initial": "M.",
                    "last": "Dong"
                }
            ],
            "doi": "10.1038/nature19799",
            "firstpage": "350",
            "issn": "00280836",
            "lastpage": "355",
            "pmid": "27680706",
            "pub_year": 2016,
            "title": "Frizzled proteins are colonic epithelial receptors for C. difficile toxin B",
            "volume": "538"
        },
        "b0155": {
            "authors": [
                {
                    "first": "Michelle E.",
                    "initial": "M.E.",
                    "last": "LaFrance"
                },
                {
                    "first": "Melissa A.",
                    "initial": "M.A.",
                    "last": "Farrow"
                },
                {
                    "first": "Ramyavardhanee",
                    "initial": "R.",
                    "last": "Chandrasekaran"
                },
                {
                    "first": "Jinsong",
                    "initial": "J.",
                    "last": "Sheng"
                },
                {
                    "first": "Donald H.",
                    "initial": "D.H.",
                    "last": "Rubin"
                },
                {
                    "first": "D. Borden",
                    "initial": "D.B.",
                    "last": "Lacy"
                }
            ],
            "doi": "10.1073/pnas.1500791112",
            "firstpage": "7073",
            "issn": "00278424",
            "lastpage": "7078",
            "pmid": "26038560",
            "pub_year": 2015,
            "title": "Identification of an epithelial cell receptor responsible for Clostridium difficile TcdB-induced cytotoxicity",
            "volume": "112"
        },
        "b0160": {
            "authors": [
                {
                    "first": "Pulkit",
                    "initial": "P.",
                    "last": "Gupta"
                },
                {
                    "first": "Zhifen",
                    "initial": "Z.",
                    "last": "Zhang"
                },
                {
                    "first": "Seiji N.",
                    "initial": "S.N.",
                    "last": "Sugiman-Marangos"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Tam"
                },
                {
                    "first": "Swetha",
                    "initial": "S.",
                    "last": "Raman"
                },
                {
                    "first": "Jean Phillipe",
                    "initial": "J.P.",
                    "last": "Julien"
                },
                {
                    "first": "Heather K.",
                    "initial": "H.K.",
                    "last": "Kroh"
                },
                {
                    "first": "D. Borden",
                    "initial": "D.B.",
                    "last": "Lacy"
                },
                {
                    "first": "Nicholas",
                    "initial": "N.",
                    "last": "Murgolo"
                },
                {
                    "first": "Kavitha",
                    "initial": "K.",
                    "last": "Bekkari"
                },
                {
                    "first": "Alex G.",
                    "initial": "A.G.",
                    "last": "Therien"
                },
                {
                    "first": "Lorraine D.",
                    "initial": "L.D.",
                    "last": "Hernandez"
                },
                {
                    "first": "Roman A.",
                    "initial": "R.A.",
                    "last": "Melnyk"
                }
            ],
            "doi": "10.1074/jbc.M117.806687",
            "firstpage": "17290",
            "issn": "00219258",
            "lastpage": "17301",
            "pmid": "28842504",
            "pub_year": 2017,
            "title": "Functional defects in Clostridium difficile TcdB toxin uptake identify CSPG4 receptor-binding determinants",
            "volume": "292"
        },
        "b0165": {
            "authors": [
                {
                    "first": "Sebastian D.",
                    "initial": "S.D.",
                    "last": "Goy"
                },
                {
                    "first": "Alexandra",
                    "initial": "A.",
                    "last": "Olling"
                },
                {
                    "first": "Detlef",
                    "initial": "D.",
                    "last": "Neumann"
                },
                {
                    "first": "Andreas",
                    "initial": "A.",
                    "last": "Pich"
                },
                {
                    "first": "Ralf",
                    "initial": "R.",
                    "last": "Gerhard"
                }
            ],
            "doi": "10.1111/cmi.12410",
            "firstpage": "893",
            "issn": "14625814",
            "lastpage": "909",
            "pmid": "25529763",
            "pub_year": 2015,
            "title": "Human neutrophils are activated by a peptide fragment of Clostridium difficile toxin B presumably via formyl peptide receptor",
            "volume": "17"
        },
        "b0170": {
            "authors": [
                {
                    "first": "Brett",
                    "initial": "B.",
                    "last": "Geissler"
                },
                {
                    "first": "Rehman",
                    "initial": "R.",
                    "last": "Tungekar"
                },
                {
                    "first": "Karla J.F.",
                    "initial": "K.J.F.",
                    "last": "Satchell"
                }
            ],
            "doi": "10.1073/pnas.0908700107",
            "firstpage": "5581",
            "issn": "00278424",
            "lastpage": "5586",
            "pmid": "20212166",
            "pub_year": 2010,
            "title": "Identification of a conserved membrane localization domain within numerous large bacterial protein toxins",
            "volume": "107"
        },
        "b0175": {
            "authors": [
                {
                    "first": "Pengfei",
                    "initial": "P.",
                    "last": "Yuan"
                },
                {
                    "first": "Hongmin",
                    "initial": "H.",
                    "last": "Zhang"
                },
                {
                    "first": "Changzu",
                    "initial": "C.",
                    "last": "Cai"
                },
                {
                    "first": "Shiyou",
                    "initial": "S.",
                    "last": "Zhu"
                },
                {
                    "first": "Yuexin",
                    "initial": "Y.",
                    "last": "Zhou"
                },
                {
                    "first": "Xiaozhou",
                    "initial": "X.",
                    "last": "Yang"
                },
                {
                    "first": "Ruina",
                    "initial": "R.",
                    "last": "He"
                },
                {
                    "first": "Chan",
                    "initial": "C.",
                    "last": "Li"
                },
                {
                    "first": "Shengjie",
                    "initial": "S.",
                    "last": "Guo"
                },
                {
                    "first": "Shan",
                    "initial": "S.",
                    "last": "Li"
                },
                {
                    "first": "Tuxiong",
                    "initial": "T.",
                    "last": "Huang"
                },
                {
                    "first": "Gregorio",
                    "initial": "G.",
                    "last": "Perez-Cordon"
                },
                {
                    "first": "Hanping",
                    "initial": "H.",
                    "last": "Feng"
                },
                {
                    "first": "Wensheng",
                    "initial": "W.",
                    "last": "Wei"
                }
            ],
            "doi": "10.1038/cr.2014.169",
            "firstpage": "157",
            "issn": "10010602",
            "lastpage": "168",
            "pmid": "25547119",
            "pub_year": 2015,
            "title": "Chondroitin sulfate proteoglycan 4 functions as the cellular receptor for Clostridium difficile toxin B",
            "volume": "25"
        },
        "b0180": {
            "authors": [
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Orth"
                },
                {
                    "first": "Li",
                    "initial": "L.",
                    "last": "Xiao"
                },
                {
                    "first": "Lorraine D.",
                    "initial": "L.D.",
                    "last": "Hernandez"
                },
                {
                    "first": "Paul",
                    "initial": "P.",
                    "last": "Reichert"
                },
                {
                    "first": "Payal R.",
                    "initial": "P.R.",
                    "last": "Sheth"
                },
                {
                    "first": "Maribel",
                    "initial": "M.",
                    "last": "Beaumont"
                },
                {
                    "first": "Xiaoyu",
                    "initial": "X.",
                    "last": "Yang"
                },
                {
                    "first": "Nicholas",
                    "initial": "N.",
                    "last": "Murgolo"
                },
                {
                    "first": "Grigori",
                    "initial": "G.",
                    "last": "Ermakov"
                },
                {
                    "first": "Edward",
                    "initial": "E.",
                    "last": "Dinunzio"
                },
                {
                    "first": "Fred",
                    "initial": "F.",
                    "last": "Racine"
                },
                {
                    "first": "Jerzy",
                    "initial": "J.",
                    "last": "Karczewski"
                },
                {
                    "first": "Susan",
                    "initial": "S.",
                    "last": "Secore"
                },
                {
                    "first": "Richard N.",
                    "initial": "R.N.",
                    "last": "Ingram"
                },
                {
                    "first": "Todd",
                    "initial": "T.",
                    "last": "Mayhood"
                },
                {
                    "first": "Corey",
                    "initial": "C.",
                    "last": "Strickland"
                },
                {
                    "first": "Alex G.",
                    "initial": "A.G.",
                    "last": "Therien"
                }
            ],
            "doi": "10.1074/jbc.M114.560748",
            "firstpage": "18008",
            "issn": "00219258",
            "lastpage": "18021",
            "pmid": "24821719",
            "pub_year": 2014,
            "title": "Mechanism of action and epitopes of Clostridium difficile toxin B-neutralizing antibody bezlotoxumab revealed by X-ray crystallography",
            "volume": "289"
        },
        "b0185": {
            "authors": [
                {
                    "first": "Ginamarie",
                    "initial": "G.",
                    "last": "Foglia"
                },
                {
                    "first": "Siddhi",
                    "initial": "S.",
                    "last": "Shah"
                },
                {
                    "first": "Christine",
                    "initial": "C.",
                    "last": "Luxemburger"
                },
                {
                    "first": "Patricia J.Freda",
                    "initial": "P.J.F.",
                    "last": "Pietrobon"
                }
            ],
            "doi": "10.1016/j.vaccine.2012.01.056",
            "firstpage": "4307",
            "issn": "0264410X",
            "lastpage": "4309",
            "pmid": "22682287",
            "pub_year": 2012,
            "title": "Clostridium difficile: Development of a novel candidate vaccine",
            "volume": "30"
        },
        "b0190": {
            "authors": [
                {
                    "first": "Guy",
                    "initial": "G.",
                    "last": "de Bruyn"
                },
                {
                    "first": "Jamshid",
                    "initial": "J.",
                    "last": "Saleh"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Workman"
                },
                {
                    "first": "Richard",
                    "initial": "R.",
                    "last": "Pollak"
                },
                {
                    "first": "Victor",
                    "initial": "V.",
                    "last": "Elinoff"
                },
                {
                    "first": "Neil J.",
                    "initial": "N.J.",
                    "last": "Fraser"
                },
                {
                    "first": "Gigi",
                    "initial": "G.",
                    "last": "Lefebvre"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Martens"
                },
                {
                    "first": "Richard E.",
                    "initial": "R.E.",
                    "last": "Mills"
                },
                {
                    "first": "Richard",
                    "initial": "R.",
                    "last": "Nathan"
                },
                {
                    "first": "Miguel",
                    "initial": "M.",
                    "last": "Trevino"
                },
                {
                    "first": "Martin",
                    "initial": "M.",
                    "last": "van Cleeff"
                },
                {
                    "first": "Ginamarie",
                    "initial": "G.",
                    "last": "Foglia"
                },
                {
                    "first": "Ayca",
                    "initial": "A.",
                    "last": "Ozol-Godfrey"
                },
                {
                    "first": "Dhaval M.",
                    "initial": "D.M.",
                    "last": "Patel"
                },
                {
                    "first": "Patricia J.",
                    "initial": "P.J.",
                    "last": "Pietrobon"
                },
                {
                    "first": "Richard",
                    "initial": "R.",
                    "last": "Gesser"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Arslanian"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Gagianas"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Brookmyre"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Christensen"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Cook"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Earl"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "Eder"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Evans"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Glover"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Haselby"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Henry"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Hoekstra"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Radin"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Rosen"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Rubino"
                },
                {
                    "first": "N.",
                    "initial": "N.",
                    "last": "Segall"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "White"
                },
                {
                    "first": "B.",
                    "initial": "B.",
                    "last": "Yangco"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Zakko"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Ervin"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Casanova"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Griffin"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "Weiner"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Barish"
                },
                {
                    "first": "O.",
                    "initial": "O.",
                    "last": "Kapoor"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Fernandez"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Epstein"
                },
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Poling"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Lesh"
                },
                {
                    "first": "V.",
                    "initial": "V.",
                    "last": "Challa"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Farrington"
                },
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Bauch"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Chen"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Arora"
                },
                {
                    "first": null,
                    "initial": null,
                    "last": null
                }
            ],
            "doi": "10.1016/j.vaccine.2016.03.028",
            "firstpage": "2170",
            "issn": "0264410X",
            "lastpage": "2178",
            "pmid": "27013431",
            "pub_year": 2016,
            "title": "Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trial",
            "volume": "34"
        },
        "b0195": {
            "authors": [
                {
                    "first": "Stavros",
                    "initial": "S.",
                    "last": "Sougioultzis"
                },
                {
                    "first": "Lorraine",
                    "initial": "L.",
                    "last": "Kyne"
                },
                {
                    "first": "Denise",
                    "initial": "D.",
                    "last": "Drudy"
                },
                {
                    "first": "Sarah",
                    "initial": "S.",
                    "last": "Keates"
                },
                {
                    "first": "Seema",
                    "initial": "S.",
                    "last": "Maroo"
                },
                {
                    "first": "Charalabos",
                    "initial": "C.",
                    "last": "Pothoulakis"
                },
                {
                    "first": "Paul J.",
                    "initial": "P.J.",
                    "last": "Giannasca"
                },
                {
                    "first": "Cynthia K.",
                    "initial": "C.K.",
                    "last": "Lee"
                },
                {
                    "first": "Michel",
                    "initial": "M.",
                    "last": "Warny"
                },
                {
                    "first": "Thomas P.",
                    "initial": "T.P.",
                    "last": "Monath"
                },
                {
                    "first": "Ciar\u00e1n P.",
                    "initial": "C.P.",
                    "last": "Kelly"
                }
            ],
            "doi": "10.1053/j.gastro.2004.11.004",
            "firstpage": "764",
            "issn": "00165085",
            "lastpage": "770",
            "pmid": "15765411",
            "pub_year": 2005,
            "title": "Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea",
            "volume": "128"
        },
        "b0200": {
            "authors": [
                {
                    "first": "Natalie G.",
                    "initial": "N.G.",
                    "last": "Anosova"
                },
                {
                    "first": "Anna M.",
                    "initial": "A.M.",
                    "last": "Brown"
                },
                {
                    "first": "Lu",
                    "initial": "L.",
                    "last": "Li"
                },
                {
                    "first": "Nana",
                    "initial": "N.",
                    "last": "Liu"
                },
                {
                    "first": "Leah E.",
                    "initial": "L.E.",
                    "last": "Cole"
                },
                {
                    "first": "Jinrong",
                    "initial": "J.",
                    "last": "Zhang"
                },
                {
                    "first": "Hersh",
                    "initial": "H.",
                    "last": "Mehta"
                },
                {
                    "first": "Harry",
                    "initial": "H.",
                    "last": "Kleanthous"
                }
            ],
            "doi": "10.1099/jmm.0.056796-0",
            "firstpage": "1394",
            "issn": "00222615",
            "lastpage": "1404",
            "pmid": "23518659",
            "pub_year": 2013,
            "title": "Systemic antibody responses induced by a two-component Clostridium difficile toxoid vaccine protect against C. difficile-associated disease in hamsters",
            "volume": "62"
        }
    },
    "body_text": [
        {
            "endOffset": 48278,
            "parents": [],
            "refoffsets": {
                "b0110": {
                    "endOffset": 48277,
                    "startOffset": 48273
                }
            },
            "secId": "s0100",
            "sentence": "A prior publication showed that the TcdB concentration in stool samples collected from CDI patients prior to treatment ranged from 4.9 to 413.1 pM [22].",
            "startOffset": 48126,
            "title": "Discussion"
        },
        {
            "endOffset": 42464,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "To examine the limits of increasing the domain coverage we assessed the impact of adding a single anti-CTD mAbs (B6) to the already potent cocktail of the five GTD-specific mAbs (B1, B2, B9, B19, and B20) (Fig. 3) in the Vero cell cytotoxicity assay.",
            "startOffset": 42214,
            "title": "Enhancement of neutralizing activity of human anti-TcdB mAbs to different toxin domains when used in combination"
        },
        {
            "endOffset": 24717,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                },
                {
                    "id": "s0015",
                    "title": "Recombinant C. difficile toxin fragment preparation"
                }
            ],
            "refoffsets": {
                "b0180": {
                    "endOffset": 24716,
                    "startOffset": 24712
                }
            },
            "secId": "s0020",
            "sentence": "Subfragments of the CTD; CROP B1, CROP B2, CROP B3, and CROP B4, were made as previously described [36].",
            "startOffset": 24613,
            "title": "Generation of domain mapping reagents"
        },
        {
            "endOffset": 37384,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0065",
            "sentence": "The controls consisted of at least one well per plate of toxin challenged without antibody and one well containing medium only.",
            "startOffset": 37257,
            "title": "Transepithelial electrical resistance C. difficile TcdB neutralization assay"
        },
        {
            "endOffset": 41748,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "The combination of mAbs specific to the GTD domain showed the best neutralizing potency (Fig. 1) while the combination of only CTD-specific mAbs showed no activity against the elevated TcdB concentrations.",
            "startOffset": 41543,
            "title": "Enhancement of neutralizing activity of human anti-TcdB mAbs to different toxin domains when used in combination"
        },
        {
            "endOffset": 52907,
            "parents": [],
            "secId": "s0100",
            "sentence": "With the impact of targeting multiple toxin domains demonstrated, the next question is how are these antibodies functioning in concert to mediate this synergistic effect.",
            "startOffset": 52737,
            "title": "Discussion"
        },
        {
            "endOffset": 36825,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0065",
            "sentence": "Purified C. difficile toxinotype 0 TcdB used in the assay was produced in-house from the reference strain VPI 10463 (ATCC 43255).",
            "startOffset": 36696,
            "title": "Transepithelial electrical resistance C. difficile TcdB neutralization assay"
        },
        {
            "endOffset": 24047,
            "parents": [],
            "secId": "s0005",
            "sentence": "This indicates that immunization with a toxoid vaccine candidate induces toxin neutralizing antibodies that bind epitopes located in multiple toxin domains.",
            "startOffset": 23891,
            "title": "Introduction"
        },
        {
            "endOffset": 25767,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                },
                {
                    "id": "s0015",
                    "title": "Recombinant C. difficile toxin fragment preparation"
                }
            ],
            "secId": "s0025",
            "sentence": "Cells were pelleted by centrifugation, lysed by passage through a Y-110 Microfluidizer (Microfluidics, USA), and the soluble proteins were purified by nickel-affinity resin in batch mode followed by bind-and-elute chromatography on a HiTrap Q Sepharose HP column.",
            "startOffset": 25504,
            "title": "Cloning, expression, and purification of the MLD and ASE fragments of TcdB"
        },
        {
            "endOffset": 54574,
            "parents": [],
            "secId": "s0100",
            "sentence": "We demonstrated that while individual mAbs specific to multiple toxin domains can neutralize toxin there is a synergistic impact of targeting multiple domains.",
            "startOffset": 54415,
            "title": "Discussion"
        },
        {
            "endOffset": 35046,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0060",
            "sentence": "The recombinant toxin fragments of the GTD, CTD of TcdA and B4 (GTD), B1 (CPD + FPR), and CROP B1 (CTD) of TcdB (Table 1) were used for inhibition studies.",
            "startOffset": 34891,
            "title": "Vero cell-based C. difficile toxin neutralization assay"
        },
        {
            "endOffset": 26149,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "It was also used to investigate binding of some mAbs to the CTD.",
            "startOffset": 26085,
            "title": "Dot blotting"
        },
        {
            "endOffset": 31459,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0050",
            "sentence": "Post challenge, animals were monitored at least twice a day for body weight, morbidity and mortality.",
            "startOffset": 31358,
            "title": "Generation of C. difficile toxoid vaccine candidate-induced sera in hamsters"
        },
        {
            "endOffset": 40895,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "All the mAbs used in these combinations neutralized toxins in at least one of the two in vitro assays (Table 3), therefore in order to differentiate the neutralizing potencies of combinations of anti-TcdB mAbs, a more stringent \u201cstress test\u201d version of in vitro toxin neutralization assays was needed.",
            "startOffset": 40594,
            "title": "Enhancement of neutralizing activity of human anti-TcdB mAbs to different toxin domains when used in combination"
        },
        {
            "endOffset": 49236,
            "parents": [],
            "secId": "s0100",
            "sentence": "The toxin neutralization that results from the combination of mAbs indicates a true synergistic effect and the increase was not simply additive, but multiplicative or better.",
            "startOffset": 49062,
            "title": "Discussion"
        },
        {
            "endOffset": 29257,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "The sensors were then transferred to wells containing mAb at a concentrations ranging from 5 to 10 \u03bcg/ml in KB and the accumulation of antibody on the sensors was measured for 300 s. Next, the sensors were transferred to wells containing only KB for 300 s to wash off nonspecifically bound proteins.",
            "startOffset": 28958,
            "title": "Fort\u00e9bio Octet assessments"
        },
        {
            "endOffset": 47717,
            "parents": [],
            "refoffsets": {
                "b0100": {
                    "endOffset": 47568,
                    "startOffset": 47564
                }
            },
            "secId": "s0100",
            "sentence": "As prior fort\u00e9BIO Octet analyses showed that these 39 human mAbs had similar binding affinity to their respective toxins [20]; this suggested that the differences observed in neutralizing activity resulted from differences in the epitopes bound and not mAb binding affinity.",
            "startOffset": 47443,
            "title": "Discussion"
        },
        {
            "endOffset": 35501,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0060",
            "sentence": "After 72 h of incubation at 37 \u00b0C with 5% CO2, the antibody-toxin or antibody-toxin-toxin fragment mixture was removed and the cells were washed twice with 120 \u00b5l of L-glutamine, FBS and phenol red-free MEM medium and 100 \u00b5l of the medium and 10 \u00b5l of AlamarBlue (Invitrogen) were added to each well.",
            "startOffset": 35201,
            "title": "Vero cell-based C. difficile toxin neutralization assay"
        },
        {
            "endOffset": 42213,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "The potencies of these mAb combinations were not distinguishable after 2.5 hrs of exposure to the TcdB, however, by 5 hrs of exposure, the GTD only combination continued to exhibit a potent neutralizing response, whereas the cocktail of the CTD-specific mAbs showed considerable impairment of its ability to protect the cell monolayer against intoxication (Fig. 2).",
            "startOffset": 41848,
            "title": "Enhancement of neutralizing activity of human anti-TcdB mAbs to different toxin domains when used in combination"
        },
        {
            "endOffset": 43940,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "This increased domain coverage increased the neutralizing potency compared to what was observed after targeting only two domains (Fig. 4).",
            "startOffset": 43802,
            "title": "Enhancement of neutralizing activity of human anti-TcdB mAbs to different toxin domains when used in combination"
        },
        {
            "endOffset": 46914,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0095",
            "sentence": "We hypothesized that polyclonal serum containing a mixture of different toxin domain specific neutralizing antibodies would be very effective against increasing concentrations of purified native TcdA and TcdB of toxinotype III.",
            "startOffset": 46687,
            "title": "High neutralizing potency of vaccine candidate-induced polyclonal sera against elevated concentrations of both C. difficile toxins"
        },
        {
            "endOffset": 21559,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 21558,
                    "startOffset": 21555
                }
            },
            "secId": "s0005",
            "sentence": "The primary virulence factors for C. difficile are the large clostridia toxins, TcdA and TcdB [1].",
            "startOffset": 21461,
            "title": "Introduction"
        },
        {
            "endOffset": 48454,
            "parents": [],
            "secId": "s0100",
            "sentence": "The highest TcdB concentrations assessed in the stress versions of these toxin neutralization assays were 117.29 pM and 0.83 nM for the Vero cell and TEER assays respectively.",
            "startOffset": 48279,
            "title": "Discussion"
        },
        {
            "endOffset": 52263,
            "parents": [],
            "secId": "s0100",
            "sentence": "For TcdB, the toxin neutralizing epitopes were spread across 3 domains, CTD, GTD, and CPD + PFR.",
            "startOffset": 52167,
            "title": "Discussion"
        },
        {
            "endOffset": 36390,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0065",
            "sentence": "In brief, T84 human colonic carcinoma cells (ATCC CCL-248) were seeded into 0.4 \u00b5m polyester transwell plates (Costar) at a seeding density of 3.6 \u00d7 105 cells/cm2.",
            "startOffset": 36227,
            "title": "Transepithelial electrical resistance C. difficile TcdB neutralization assay"
        },
        {
            "endOffset": 33065,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0055",
            "sentence": "Plates were developed with the addition of the TMB substrate (KPL) for 20 min at 37 \u00b0C and then read at 650 nm using a Molecular Devices plate reader and SoftMax Pro software.",
            "startOffset": 32890,
            "title": "Indirect ELISA with recombinant toxin domain fragments"
        },
        {
            "endOffset": 45283,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "Immunoabsorption with recombinant fragments was performed to determine the contribution of antibodies specific to different toxin domains to the neutralizing activity of polyclonal sera.",
            "startOffset": 45097,
            "title": "Inhibition of neutralizing activity of immune sera with C. difficile toxin recombinant fragments"
        },
        {
            "endOffset": 38991,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "The remaining 7% of anti-TcdA mAbs could not be mapped to the available fragments.",
            "startOffset": 38909,
            "title": "Mapping of human C. difficile toxin neutralizing mAbs at toxin domain level"
        },
        {
            "endOffset": 45673,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "If those antibodies were necessary for toxin neutralization, the addition of the recombinant fragment(s) should inhibit the antibody mediated toxin neutralization.",
            "startOffset": 45510,
            "title": "Inhibition of neutralizing activity of immune sera with C. difficile toxin recombinant fragments"
        },
        {
            "endOffset": 40096,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "These differences could stem from differences in the assays themselves including the different cells used, toxin concentrations, or functional readouts for each assay.",
            "startOffset": 39929,
            "title": "Mapping of human C. difficile toxin neutralizing mAbs at toxin domain level"
        },
        {
            "endOffset": 33987,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0060",
            "sentence": "For the antibody-dependent toxin neutralization assay, hamster immune sera or mAbs were mixed with the toxins at the concentrations noted in the figures.",
            "startOffset": 33834,
            "title": "Vero cell-based C. difficile toxin neutralization assay"
        },
        {
            "endOffset": 47064,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0095",
            "sentence": "Polyclonal vaccine candidate-induced sera retained protective activity against toxin concentrations of 51 pM for TcdA and 36.84 pM for TcdB (Fig. 7).",
            "startOffset": 46915,
            "title": "High neutralizing potency of vaccine candidate-induced polyclonal sera against elevated concentrations of both C. difficile toxins"
        },
        {
            "endOffset": 21460,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 21459,
                    "startOffset": 21456
                }
            },
            "secId": "s0005",
            "sentence": "Clostridium difficile infection (CDI) is a serious and increasingly common problem; in 2011 there were estimated to be half a million CDI and 29,000 deaths associated with CDI in the United States [1].",
            "startOffset": 21259,
            "title": "Introduction"
        },
        {
            "endOffset": 26299,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Briefly, 0.2 \u03bcg of protein (TcdA, TcdB or their recombinant CTDs) in 5 \u03bcl of PBS was spotted onto a Nitrocellulose membrane with a 0.45 \u03bcm pore size.",
            "startOffset": 26150,
            "title": "Dot blotting"
        },
        {
            "endOffset": 38414,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0100": {
                    "endOffset": 38413,
                    "startOffset": 38409
                }
            },
            "secId": "s0075",
            "sentence": "In a prior publication the identification, selection, and generation of recombinant toxin-neutralizing human mAbs was described [20].",
            "startOffset": 38281,
            "title": "Mapping of human C. difficile toxin neutralizing mAbs at toxin domain level"
        },
        {
            "endOffset": 44632,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "Out of all antibodies binding a full length TcdA, 54% and 9% were attributed as being specific to CTD and GTD regions of TcdA, respectively.",
            "startOffset": 44492,
            "title": "Mapping toxoid vaccine candidate-induced sera antibodies at toxin domain level"
        },
        {
            "endOffset": 34434,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0060",
            "sentence": "For the immunoabsorption assays, recombinant fragments of TcdA and TcdB were mixed at the indicated concentrations with hamster immune sera at final dilutions of 1:12000 or 1:14000 for TcdA assays or 1:8000 for TcdB assays and either TcdA or TcdB at final concentration of 4 \u00d7 MC50 which is 7.8 pM and 53.63fM, respectively.",
            "startOffset": 34110,
            "title": "Vero cell-based C. difficile toxin neutralization assay"
        },
        {
            "endOffset": 51631,
            "parents": [],
            "secId": "s0100",
            "sentence": "Having demonstrated a synergistic impact of combining mAbs across domains, we next examined sera from C. difficile toxoid vaccine candidate immunized hamsters to assess the role that antibody domain specificity plays in sera-mediated toxin neutralization.",
            "startOffset": 51376,
            "title": "Discussion"
        },
        {
            "endOffset": 37136,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0065",
            "sentence": "TcdB TEER assays were performed by adding TcdB -antibody combinations to the lower compartment of the transwell.",
            "startOffset": 37024,
            "title": "Transepithelial electrical resistance C. difficile TcdB neutralization assay"
        },
        {
            "endOffset": 36449,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0065",
            "sentence": "T84 cells are derived from a human colonic adenocarcinoma.",
            "startOffset": 36391,
            "title": "Transepithelial electrical resistance C. difficile TcdB neutralization assay"
        },
        {
            "endOffset": 54304,
            "parents": [],
            "secId": "s0100",
            "sentence": "Another potential mechanism is that attached antibodies could be internalized into cells with the toxin and then subsequently block toxin functions downstream of cell adhesion.",
            "startOffset": 54128,
            "title": "Discussion"
        },
        {
            "endOffset": 26504,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "The membrane was blocked by incubation in 5% dry milk in phosphate buffered saline (PBS) with 0.1% Tween-20 (PBST), 1 h at room temperature (RT) with agitation or overnight (ON) at 4 \u00b0C without agitation.",
            "startOffset": 26300,
            "title": "Dot blotting"
        },
        {
            "endOffset": 24612,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                },
                {
                    "id": "s0015",
                    "title": "Recombinant C. difficile toxin fragment preparation"
                }
            ],
            "refoffsets": {
                "b0100": {
                    "endOffset": 24611,
                    "startOffset": 24607
                }
            },
            "secId": "s0020",
            "sentence": "The CTDs of TcdA and TcdB as well as the GTD and TLD of TcdA and the GTD, TLD and CPD + PFR of TcdB were cloned, overexpressed, and purified as previously detailed [20].",
            "startOffset": 24443,
            "title": "Generation of domain mapping reagents"
        },
        {
            "endOffset": 48902,
            "parents": [],
            "secId": "s0100",
            "sentence": "We created cocktails of non-overlapping mAbs that bound epitopes located in either one, two, or all the major domains of the TcdB.",
            "startOffset": 48772,
            "title": "Discussion"
        },
        {
            "endOffset": 44354,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "Immune pre-challenge sera from hamsters that survived subsequent challenge with lethal dose of C. difficile were used.",
            "startOffset": 44236,
            "title": "Mapping toxoid vaccine candidate-induced sera antibodies at toxin domain level"
        },
        {
            "endOffset": 27084,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "The membrane was once again washed 3\u00d7 for 5 min with PBST at RT with agitation before development with the colorimetric substrate 5-bromo-4-chloro-3-indolyl-phosphate/nitro blue tetrazolium (BCIP/NBT).",
            "startOffset": 26883,
            "title": "Dot blotting"
        },
        {
            "endOffset": 50800,
            "parents": [],
            "refoffsets": {
                "b0115": {
                    "endOffset": 50799,
                    "startOffset": 50795
                }
            },
            "secId": "s0100",
            "sentence": "The combination of two murine mAbs to the CTD region of TcdA demonstrated significantly more toxin neutralization than the same concentration of the two mAbs individually [23].",
            "startOffset": 50624,
            "title": "Discussion"
        },
        {
            "endOffset": 38656,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "Using recombinant toxin domain fragments (Table 1) and a combination of techniques including Western immunoblotting, dot blotting and Fort\u00e9bio Octet binding assessments, the domain specificity of 33 of these 39 mAbs was determined (Table 2).",
            "startOffset": 38415,
            "title": "Mapping of human C. difficile toxin neutralizing mAbs at toxin domain level"
        },
        {
            "endOffset": 51810,
            "parents": [],
            "secId": "s0100",
            "sentence": "Mapping and immunoabsorption studies demonstrated that immunization with a toxoid vaccine candidate elicited neutralizing antibodies that were specific to multiple toxin domains.",
            "startOffset": 51632,
            "title": "Discussion"
        },
        {
            "endOffset": 30547,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0050",
            "sentence": "Female Golden Syrian hamsters (Mesocricetus auratus) from Charles River Laboratories (Germany), 70\u201390 g, were used for immunization and challenge studies.",
            "startOffset": 30393,
            "title": "Generation of C. difficile toxoid vaccine candidate-induced sera in hamsters"
        },
        {
            "endOffset": 30679,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0050",
            "sentence": "Hamsters were injected three times via the intramuscular route, two weeks apart with 5 \u00b5g of C. difficile toxoid vaccine candidate.",
            "startOffset": 30548,
            "title": "Generation of C. difficile toxoid vaccine candidate-induced sera in hamsters"
        },
        {
            "endOffset": 31501,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0050",
            "sentence": "All immunized animals survived challenge.",
            "startOffset": 31460,
            "title": "Generation of C. difficile toxoid vaccine candidate-induced sera in hamsters"
        },
        {
            "endOffset": 29434,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Changes in thickness of the protein layer were measured and binding was recorded if observed.",
            "startOffset": 29341,
            "title": "Fort\u00e9bio Octet assessments"
        },
        {
            "endOffset": 27234,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "SDS-PAGE and Western Blotting (WB) were performed to investigate mAb binding to purified, recombinant toxin fragments.",
            "startOffset": 27116,
            "title": "SDS-PAGE and Western Blotting"
        },
        {
            "endOffset": 26084,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Dot blotting (DB) was performed to confirm binding of each mAb to full length TcdA and TcdB.",
            "startOffset": 25992,
            "title": "Dot blotting"
        },
        {
            "endOffset": 36592,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0065",
            "sentence": "The cells were maintained at 37 \u00b0C with 5% CO2 in complete culture medium for 10\u201312 days until stable transepithelial resistance was achieved.",
            "startOffset": 36450,
            "title": "Transepithelial electrical resistance C. difficile TcdB neutralization assay"
        },
        {
            "endOffset": 43679,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "Finally, as there was a clear impact of increasing coverage to two domains, we wanted to assess the impact of combining mAbs to multiple domains.",
            "startOffset": 43534,
            "title": "Enhancement of neutralizing activity of human anti-TcdB mAbs to different toxin domains when used in combination"
        },
        {
            "endOffset": 26882,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "The membrane was washed 3x for 5 min with PBST at RT with agitation prior to incubation with the appropriate secondary antibody (goat anti-human IgG, alkaline phosphatase-labeled) diluted 1:1000 in PBST.",
            "startOffset": 26679,
            "title": "Dot blotting"
        },
        {
            "endOffset": 36695,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0065",
            "sentence": "Medium was replaced in both the upper and lower compartments daily from day 6 and on the day of assay.",
            "startOffset": 36593,
            "title": "Transepithelial electrical resistance C. difficile TcdB neutralization assay"
        },
        {
            "endOffset": 38164,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0065",
            "sentence": "Testing was performed in at least three separate experiments.",
            "startOffset": 38103,
            "title": "Transepithelial electrical resistance C. difficile TcdB neutralization assay"
        },
        {
            "endOffset": 44235,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "Having shown the benefit of combining toxin neutralizing mAbs to multiple domains, we wanted to assess the domain specificity of the antibodies elicited by immunization with a toxoid C. difficile vaccine candidate.",
            "startOffset": 44021,
            "title": "Mapping toxoid vaccine candidate-induced sera antibodies at toxin domain level"
        },
        {
            "endOffset": 52166,
            "parents": [],
            "secId": "s0100",
            "sentence": "For TcdA, the toxin neutralizing epitopes were located in the CTD and GTD domains.",
            "startOffset": 52084,
            "title": "Discussion"
        },
        {
            "endOffset": 30047,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0050",
            "sentence": "All animal experiments were performed in compliance with European Directive 2010/63 and national regulations.",
            "startOffset": 29938,
            "title": "Generation of C. difficile toxoid vaccine candidate-induced sera in hamsters"
        },
        {
            "endOffset": 38763,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "The 6 mAbs which bound to holotoxin but not to any of the recombinant domains were designated as unmapped.",
            "startOffset": 38657,
            "title": "Mapping of human C. difficile toxin neutralizing mAbs at toxin domain level"
        },
        {
            "endOffset": 24442,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                },
                {
                    "id": "s0015",
                    "title": "Recombinant C. difficile toxin fragment preparation"
                }
            ],
            "secId": "s0020",
            "sentence": "Recombinant C. difficile toxin fragments used in the study are listed in Table 1.",
            "startOffset": 24361,
            "title": "Generation of domain mapping reagents"
        },
        {
            "endOffset": 38102,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0065",
            "sentence": "Results in the Table 3 are shown as NT50 and maximum % completeness defined as antibody concentrations providing 50% neutralization and maximum neutralization at the highest antibody concentration tested.",
            "startOffset": 37898,
            "title": "Transepithelial electrical resistance C. difficile TcdB neutralization assay"
        },
        {
            "endOffset": 41346,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "When assessed using the \u201cstress\u201d Vero cell test, none of the individual mAbs exhibited neutralizing activity against TcdB concentrations of >1.45 pM (data not shown).",
            "startOffset": 41180,
            "title": "Enhancement of neutralizing activity of human anti-TcdB mAbs to different toxin domains when used in combination"
        },
        {
            "endOffset": 31917,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0055",
            "sentence": "Pre-challenge sera from the C. difficile vaccine candidate immunized animals were tested.",
            "startOffset": 31828,
            "title": "Indirect ELISA with recombinant toxin domain fragments"
        },
        {
            "endOffset": 36226,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0100": {
                    "endOffset": 36225,
                    "startOffset": 36221
                }
            },
            "secId": "s0065",
            "sentence": "The assay procedure was described in detail previously [20].",
            "startOffset": 36166,
            "title": "Transepithelial electrical resistance C. difficile TcdB neutralization assay"
        },
        {
            "endOffset": 38195,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0065",
            "sentence": "Intra-assay precision was 20%.",
            "startOffset": 38165,
            "title": "Transepithelial electrical resistance C. difficile TcdB neutralization assay"
        },
        {
            "endOffset": 35789,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0060",
            "sentence": "The fluorescence results were plotted over antibody concentration or over concentration of the respective recombinant fragments for the fragment inhibition studies.",
            "startOffset": 35625,
            "title": "Vero cell-based C. difficile toxin neutralization assay"
        },
        {
            "endOffset": 28621,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "The membrane was washed 3\u00d7 for 5 min with PBST at RT with agitation before development using the colorimetric substrate BCIP/NBT.",
            "startOffset": 28492,
            "title": "SDS-PAGE and Western Blotting"
        },
        {
            "endOffset": 29340,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Throughout the experiment, samples were assessed at 30 \u00b0C with 1000 rpm agitation.",
            "startOffset": 29258,
            "title": "Fort\u00e9bio Octet assessments"
        },
        {
            "endOffset": 29859,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0195": {
                    "endOffset": 29858,
                    "startOffset": 29854
                }
            },
            "secId": "s0045",
            "sentence": "For the immunization of hamsters, the vaccine candidate was reconstituted with diluent and mixed with aluminum hydroxide adjuvant using a previously described method [39].",
            "startOffset": 29688,
            "title": "C. difficile toxoid vaccine candidate"
        },
        {
            "endOffset": 28287,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "The membrane was probed with the indicated mAbs at a concentration of 0.0215 \u03bcg/mL in blocking solution for 1 h at RT with agitation or ON at 4 \u00b0C without agitation.",
            "startOffset": 28122,
            "title": "SDS-PAGE and Western Blotting"
        },
        {
            "endOffset": 33407,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0060",
            "sentence": "In brief, Vero cells were seeded in a 96 well plate at 2.5 \u00d7 104 cells/well and incubated overnight.",
            "startOffset": 33307,
            "title": "Vero cell-based C. difficile toxin neutralization assay"
        },
        {
            "endOffset": 42794,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "This result was particularly striking as the B6 mAb had no activity in the Vero cell assay when tested independently at 0.064 pM TcdB (Table 3).",
            "startOffset": 42650,
            "title": "Enhancement of neutralizing activity of human anti-TcdB mAbs to different toxin domains when used in combination"
        },
        {
            "endOffset": 25394,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                },
                {
                    "id": "s0015",
                    "title": "Recombinant C. difficile toxin fragment preparation"
                }
            ],
            "secId": "s0025",
            "sentence": "The resulting constructs had a His-tag with the sequence LPETGGHHHHHH following amino acid 91 and 586, respectively.",
            "startOffset": 25278,
            "title": "Cloning, expression, and purification of the MLD and ASE fragments of TcdB"
        },
        {
            "endOffset": 54774,
            "parents": [],
            "secId": "s0100",
            "sentence": "We showed that vaccination with a toxoid vaccine candidate induced neutralizing antibodies to multiple toxin domains specially the CTD and GTD domains of TcdA and the GTD, CTD, and CPD + PFR of TcdB.",
            "startOffset": 54575,
            "title": "Discussion"
        },
        {
            "endOffset": 28121,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "The membrane was then blocked by incubation in 5% dry milk in PBST, 1 h at RT with agitation or ON at 4 \u00b0C without agitation.",
            "startOffset": 27996,
            "title": "SDS-PAGE and Western Blotting"
        },
        {
            "endOffset": 52083,
            "parents": [],
            "secId": "s0100",
            "sentence": "Immunoabsorption experiments that mapped the domain specificities of these neutralizing antibodies demonstrated that neutralizing polyclonal antibodies were not distributed evenly across the full toxin molecules and that the domain specificity differed for the two toxins.",
            "startOffset": 51811,
            "title": "Discussion"
        },
        {
            "endOffset": 29687,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0185": {
                    "endOffset": 29646,
                    "startOffset": 29639
                },
                "b0190": {
                    "endOffset": 29646,
                    "startOffset": 29639
                }
            },
            "secId": "s0045",
            "sentence": "This C. difficile toxoid vaccine formulation is a formalin-inactivated, highly purified preparation of toxoids A and B from C. difficile reference strain VPI 10,463 [37,38] presented as a freeze-dried formulation.",
            "startOffset": 29474,
            "title": "C. difficile toxoid vaccine candidate"
        },
        {
            "endOffset": 33188,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0055",
            "sentence": "The endpoint titer was defined as the reciprocal of the highest serum sample dilution that generated OD reading above 0.1.",
            "startOffset": 33066,
            "title": "Indirect ELISA with recombinant toxin domain fragments"
        },
        {
            "endOffset": 38908,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "The majority of anti-TcdA mAbs (71%) bound to the CTD; 14% of the anti-TcdA mAbs bound to the TLD, and a smaller proportion (7%) recognized GTD.",
            "startOffset": 38764,
            "title": "Mapping of human C. difficile toxin neutralizing mAbs at toxin domain level"
        },
        {
            "endOffset": 35994,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0060",
            "sentence": "Results in the Table 3 are shown as NT50 and maximum % completeness defined as antibody concentrations providing 50% neutralization and maximum neutralization at the highest antibody concentration tested.",
            "startOffset": 35790,
            "title": "Vero cell-based C. difficile toxin neutralization assay"
        },
        {
            "endOffset": 44803,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "We did not detect binding of immune sera to the TcdB TLD fragment.",
            "startOffset": 44737,
            "title": "Mapping toxoid vaccine candidate-induced sera antibodies at toxin domain level"
        },
        {
            "endOffset": 32407,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0055",
            "sentence": "Plates were coated with 30 nM of either native purified TcdA or TcdB of designated toxin fragments in carbonate\u2013bicarbonate coating buffer, pH 9.6, overnight at 2\u00b0\u20138 \u00b0C.",
            "startOffset": 32238,
            "title": "Indirect ELISA with recombinant toxin domain fragments"
        },
        {
            "endOffset": 22734,
            "parents": [],
            "refoffsets": {
                "b0095": {
                    "endOffset": 22733,
                    "startOffset": 22729
                }
            },
            "secId": "s0005",
            "sentence": "Recent studies in humans further emphasized the importance of toxin B specific antibody in protection [19].",
            "startOffset": 22627,
            "title": "Introduction"
        },
        {
            "endOffset": 46474,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "These results suggest that immunization with C. difficile toxoids induces neutralizing antibodies that are specific to the GTD and CTD domains of TcdA and the GTD, CTD, and CPD + PFR domains of TcdB.",
            "startOffset": 46275,
            "title": "Inhibition of neutralizing activity of immune sera with C. difficile toxin recombinant fragments"
        },
        {
            "endOffset": 37827,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0065",
            "sentence": "The percent protection for antibody was calculated using the equation: (% TEER loss in toxin-only challenge) - (% TEER loss in antibody neutralized toxin challenge).",
            "startOffset": 37662,
            "title": "Transepithelial electrical resistance C. difficile TcdB neutralization assay"
        },
        {
            "endOffset": 37897,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0065",
            "sentence": "The percent protection results were plotted versus mAb concentration.",
            "startOffset": 37828,
            "title": "Transepithelial electrical resistance C. difficile TcdB neutralization assay"
        },
        {
            "endOffset": 32889,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0055",
            "sentence": "After washing, two-fold serial dilutions of serum samples were prepared in diluent 0.2% BSA in PBS\u20130.05% Tween 20 and added to the wells and incubated for 1 h. Bound antibodies were detected with (HRP)-conjugated secondary antibody goat anti-hamster IgG (H + L) (Southern Biotech) at 1:8000 dilution.",
            "startOffset": 32589,
            "title": "Indirect ELISA with recombinant toxin domain fragments"
        },
        {
            "endOffset": 25503,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                },
                {
                    "id": "s0015",
                    "title": "Recombinant C. difficile toxin fragment preparation"
                }
            ],
            "secId": "s0025",
            "sentence": "Cultures were harvested after 4 h at 37 \u00b0C.",
            "startOffset": 25460,
            "title": "Cloning, expression, and purification of the MLD and ASE fragments of TcdB"
        },
        {
            "endOffset": 48125,
            "parents": [],
            "secId": "s0100",
            "sentence": "Assessment of increasing toxin concentrations provided the \u201cstress\u201d that enabled the differentiation of combinations of mAbs in the Vero cell neutralization assay while increasing the time of incubation at a single toxin concentration enabled differentiation of mAb combinations in the TEER assay.",
            "startOffset": 47828,
            "title": "Discussion"
        },
        {
            "endOffset": 39590,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "The activities for the anti-TcdB mAbs used in the combination experiments (Figs. 1\u20134) are listed in Table 3.",
            "startOffset": 39482,
            "title": "Mapping of human C. difficile toxin neutralizing mAbs at toxin domain level"
        },
        {
            "endOffset": 53447,
            "parents": [],
            "refoffsets": {
                "b0105": {
                    "endOffset": 53360,
                    "startOffset": 53356
                },
                "b0160": {
                    "endOffset": 53446,
                    "startOffset": 53442
                }
            },
            "secId": "s0100",
            "sentence": "The clinically efficacious mAb bezlotoxumab [21] mediates its impact by blocking those sites and preventing TcdB binding to CSPG4 [32].",
            "startOffset": 53312,
            "title": "Discussion"
        },
        {
            "endOffset": 45096,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "As toxoid vaccine candidate immunization elicits antibodies that bind to multiple toxin domains, we wanted to assess the contribution of these domain-specific antibodies to toxin neutralization.",
            "startOffset": 44902,
            "title": "Inhibition of neutralizing activity of immune sera with C. difficile toxin recombinant fragments"
        },
        {
            "endOffset": 28787,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "The binding of mAbs to recombinant toxin fragments was determined by Bio-Layer Interferometry (BLI) using a Fort\u00e9Bio Octet\u00ae Red96 (Pall).",
            "startOffset": 28650,
            "title": "Fort\u00e9bio Octet assessments"
        },
        {
            "endOffset": 31357,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0050",
            "sentence": "After C. difficile challenge, animals were housed individually in cages with isocaps.",
            "startOffset": 31272,
            "title": "Generation of C. difficile toxoid vaccine candidate-induced sera in hamsters"
        },
        {
            "endOffset": 43801,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "Therefore we tested a combination of mAbs specific to the GTD (B1 and B2), TLD (B7 and B4), CPD + PFR (B24) and CTD (B6).",
            "startOffset": 43680,
            "title": "Enhancement of neutralizing activity of human anti-TcdB mAbs to different toxin domains when used in combination"
        },
        {
            "endOffset": 44491,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "Mapping of the serum antibody-binding epitopes was performed by indirect ELISA using recombinant C. difficile toxin fragments (Table 1).",
            "startOffset": 44355,
            "title": "Mapping toxoid vaccine candidate-induced sera antibodies at toxin domain level"
        },
        {
            "endOffset": 45832,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "A combination of the GTD and CTD TcdA fragments, but neither alone, completely inhibited neutralizing activity of vaccine candidate-induced sera against TcdA.",
            "startOffset": 45674,
            "title": "Inhibition of neutralizing activity of immune sera with C. difficile toxin recombinant fragments"
        },
        {
            "endOffset": 25277,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                },
                {
                    "id": "s0015",
                    "title": "Recombinant C. difficile toxin fragment preparation"
                }
            ],
            "secId": "s0025",
            "sentence": "The MLD fragment (amino acids 1\u201391) and ASE fragment (amino acids 95\u2013586) were codon-optimized for expression in E. coli by Thermo Fisher Scientific (formerly GeneArt), cloned into pET28a + using the 5\u2032 NcoI and 3\u2032 XhoI restriction sites of the multiple cloning site, and expressed in BL21 Star (DE3).",
            "startOffset": 24976,
            "title": "Cloning, expression, and purification of the MLD and ASE fragments of TcdB"
        },
        {
            "endOffset": 34890,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0060",
            "sentence": "An excess of recombinant toxin domain fragments were mixed with the immune sera to bind or absorb all of the antibodies specific to that domain thereby preventing those particular domain-specific antibodies from interacting with the toxin.",
            "startOffset": 34651,
            "title": "Vero cell-based C. difficile toxin neutralization assay"
        },
        {
            "endOffset": 53090,
            "parents": [],
            "refoffsets": {
                "b0125": {
                    "endOffset": 53089,
                    "startOffset": 53082
                },
                "b0130": {
                    "endOffset": 53089,
                    "startOffset": 53082
                },
                "b0135": {
                    "endOffset": 53089,
                    "startOffset": 53082
                },
                "b0140": {
                    "endOffset": 53089,
                    "startOffset": 53082
                },
                "b0145": {
                    "endOffset": 53089,
                    "startOffset": 53082
                },
                "b0150": {
                    "endOffset": 53089,
                    "startOffset": 53082
                },
                "b0155": {
                    "endOffset": 53089,
                    "startOffset": 53082
                }
            },
            "secId": "s0100",
            "sentence": "Three distinct cell surface receptors have been identified for TcdB and each toxin binding site could contribute to the overall avidity of the toxin for the gut cell surface [25\u201331].",
            "startOffset": 52908,
            "title": "Discussion"
        },
        {
            "endOffset": 40593,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "In order to define the most potent combination of mAbs, we examined the impact of combining more than two mAbs to a single domain as well as combining mAbs specific to multiple domains.",
            "startOffset": 40408,
            "title": "Enhancement of neutralizing activity of human anti-TcdB mAbs to different toxin domains when used in combination"
        },
        {
            "endOffset": 23024,
            "parents": [],
            "secId": "s0005",
            "sentence": "To evaluate the contributions of different domain specific antibodies to the toxin neutralizing response, we used a panel of domain mapped human anti-TcdB mAbs to assess the neutralizing capacity of combinations of mAbs that were specific either to individual or to multiple toxin domains.",
            "startOffset": 22735,
            "title": "Introduction"
        },
        {
            "endOffset": 47442,
            "parents": [],
            "secId": "s0100",
            "sentence": "The impact of antibody domain specificity on toxin neutralization was investigated using domain mapped human C. difficile toxin-neutralizing mAbs and serum from toxoid vaccine candidate immunized hamsters.",
            "startOffset": 47237,
            "title": "Discussion"
        },
        {
            "endOffset": 53744,
            "parents": [],
            "refoffsets": {
                "b0125": {
                    "endOffset": 53743,
                    "startOffset": 53736
                },
                "b0130": {
                    "endOffset": 53743,
                    "startOffset": 53736
                }
            },
            "secId": "s0100",
            "sentence": "The existence of a CROP independent receptor had previously been suspected as prior studies had demonstrated that TcdA and TcdB which lack the CROP domains are still able to bind to and intoxicate sensitive cells [25,26].",
            "startOffset": 53523,
            "title": "Discussion"
        },
        {
            "endOffset": 32461,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0055",
            "sentence": "Plates were washed between each step with PBST\u20130.05%.",
            "startOffset": 32408,
            "title": "Indirect ELISA with recombinant toxin domain fragments"
        },
        {
            "endOffset": 32060,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0055",
            "sentence": "The serum pool was created by combining equal volumes of serum samples from 11 animals that survived subsequent lethal C. difficile challenge.",
            "startOffset": 31918,
            "title": "Indirect ELISA with recombinant toxin domain fragments"
        },
        {
            "endOffset": 52736,
            "parents": [],
            "secId": "s0100",
            "sentence": "Therefore while our mAb results clearly indicate that anti-TLD mAbs can neutralize TcdB, these data suggest that this toxoid vaccine candidate may not be inducing TLD-specific neutralizing antibodies in hamsters.",
            "startOffset": 52524,
            "title": "Discussion"
        },
        {
            "endOffset": 30392,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0050",
            "sentence": "The protocols were approved by the Committee on the Ethics of Animal Experiments at Sanofi Pasteur, France and all efforts were made to reduce the use of animals and to minimize pain and distress.",
            "startOffset": 30196,
            "title": "Generation of C. difficile toxoid vaccine candidate-induced sera in hamsters"
        },
        {
            "endOffset": 42964,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "We next examined the impact of targeting domains beyond the highly immunogenic CTD and GTD domains as well as the impact of targeting different epitopes within a domain.",
            "startOffset": 42795,
            "title": "Enhancement of neutralizing activity of human anti-TcdB mAbs to different toxin domains when used in combination"
        },
        {
            "endOffset": 34650,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0060",
            "sentence": "The immune hamster sera dilutions were near top of the linear range but not within the upper asymptote as was determined in prior toxin neutralization assays performed with a 4 \u00d7 MC50 concentrations of either toxin.",
            "startOffset": 34435,
            "title": "Vero cell-based C. difficile toxin neutralization assay"
        },
        {
            "endOffset": 33632,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0060",
            "sentence": "One MC50 dose was 1.95 pM for TcdA and 0.016 pM for TcdB.",
            "startOffset": 33575,
            "title": "Vero cell-based C. difficile toxin neutralization assay"
        },
        {
            "endOffset": 44736,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "Response to TcdB was attributed to the three domains: CTD (34%), GTD (16%) and CPD + PFR (9%) (Fig. 5).",
            "startOffset": 44633,
            "title": "Mapping toxoid vaccine candidate-induced sera antibodies at toxin domain level"
        },
        {
            "endOffset": 35200,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0060",
            "sentence": "After 1 h of incubation, medium was removed from the Vero cell monolayer and 100 \u00b5l of antibody-toxin or antibody-toxin-toxin fragment mixture was added.",
            "startOffset": 35047,
            "title": "Vero cell-based C. difficile toxin neutralization assay"
        },
        {
            "endOffset": 37554,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0065",
            "sentence": "Transepithelial resistance was measured immediately (T0) before toxin-antibody sample addition and then after 2.5 h to 5 h (T2.5 \u2212 T5) of incubation at 37 \u00b0C and 5% CO2.",
            "startOffset": 37385,
            "title": "Transepithelial electrical resistance C. difficile TcdB neutralization assay"
        },
        {
            "endOffset": 51376,
            "parents": [],
            "secId": "s0100",
            "sentence": "Taken together these data create a picture that suggests that multiple antibody binding events, whether spread across a single domain or across the entire toxin molecule, can produce synergistic protection against intoxication and that the toxin neutralizing benefit of targeting multiple epitopes is a concept that applies to both TcdB and TcdA.",
            "startOffset": 51030,
            "title": "Discussion"
        },
        {
            "endOffset": 30195,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0050",
            "sentence": "Studies were conducted in animal facilities accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International.",
            "startOffset": 30048,
            "title": "Generation of C. difficile toxoid vaccine candidate-induced sera in hamsters"
        },
        {
            "endOffset": 39289,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "Nineteen percent of the anti-TcdB mAbs could not be mapped to a specific recombinant fragment.",
            "startOffset": 39195,
            "title": "Mapping of human C. difficile toxin neutralizing mAbs at toxin domain level"
        },
        {
            "endOffset": 21676,
            "parents": [],
            "refoffsets": {
                "b0010": {
                    "endOffset": 21675,
                    "startOffset": 21672
                }
            },
            "secId": "s0005",
            "sentence": "These two toxins are single chain proteins with 44% sequence identity and approximately 66% sequence similarity [2].",
            "startOffset": 21560,
            "title": "Introduction"
        },
        {
            "endOffset": 41006,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "For the Vero cell cytotoxicity assay, the combination of mAbs were evaluated at TcdB concentrations up to 117.",
            "startOffset": 40896,
            "title": "Enhancement of neutralizing activity of human anti-TcdB mAbs to different toxin domains when used in combination"
        },
        {
            "endOffset": 31195,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0050",
            "sentence": "Twenty four hours later, hamsters were challenged intragastrically, using a feeding needle, with a predetermined lethal dose of live C. difficile spore-enriched preparations of SP041 US strain, ribotype 027 or reference strain VPI 10,463 (ATCC 43255).",
            "startOffset": 30944,
            "title": "Generation of C. difficile toxoid vaccine candidate-induced sera in hamsters"
        },
        {
            "endOffset": 37661,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0065",
            "sentence": "Percent TEER loss was determined using the equation [(T0 \u2212 T2.5)/T0] \u00d7 100% - %TEER loss in negative well.",
            "startOffset": 37555,
            "title": "Transepithelial electrical resistance C. difficile TcdB neutralization assay"
        },
        {
            "endOffset": 50623,
            "parents": [],
            "secId": "s0100",
            "sentence": "However published data suggest that this synergistic impact observed with the TcdB mAbs could also apply to TcdA mAbs.",
            "startOffset": 50505,
            "title": "Discussion"
        },
        {
            "endOffset": 27840,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Blotting was performed in the iBlot dry transfer apparatus onto Nitrocellulose membrane using the iBlot transfer stack set for 6 min.",
            "startOffset": 27707,
            "title": "SDS-PAGE and Western Blotting"
        },
        {
            "endOffset": 31271,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0200": {
                    "endOffset": 31270,
                    "startOffset": 31266
                }
            },
            "secId": "s0050",
            "sentence": "C. difficile spore preparations were prepared as described previously [40].",
            "startOffset": 31196,
            "title": "Generation of C. difficile toxoid vaccine candidate-induced sera in hamsters"
        },
        {
            "endOffset": 46274,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "In the absence of immune serum, fragments of either toxins alone or in combination did not have any neutralizing effect on the respective toxin (data not shown).",
            "startOffset": 46113,
            "title": "Inhibition of neutralizing activity of immune sera with C. difficile toxin recombinant fragments"
        },
        {
            "endOffset": 23618,
            "parents": [],
            "secId": "s0005",
            "sentence": "The majority of serum antibodies elicited by immunization of hamsters with this vaccine candidate bound to the CTD and GTD domains of TcdA and the GTD, CTD, and CPD + PFR domains of TcdB.",
            "startOffset": 23431,
            "title": "Introduction"
        },
        {
            "endOffset": 25894,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                },
                {
                    "id": "s0015",
                    "title": "Recombinant C. difficile toxin fragment preparation"
                }
            ],
            "secId": "s0025",
            "sentence": "The MLD and ASE fragments were concentrated on a Vivaspin 3 K spin column and exchanged into PBS using a Zeba column (Thermo).",
            "startOffset": 25768,
            "title": "Cloning, expression, and purification of the MLD and ASE fragments of TcdB"
        },
        {
            "endOffset": 53966,
            "parents": [],
            "refoffsets": {
                "b0165": {
                    "endOffset": 53832,
                    "startOffset": 53825
                },
                "b0170": {
                    "endOffset": 53832,
                    "startOffset": 53825
                },
                "b0175": {
                    "endOffset": 53885,
                    "startOffset": 53881
                }
            },
            "secId": "s0100",
            "sentence": "Secondary cellular membrane binding motifs have also been identified in the GTD [33,34] and in amino acid residues 1371\u20131848 of the TLD [35], and data indicate that these regions can mediate endocytic uptake of the toxin.",
            "startOffset": 53745,
            "title": "Discussion"
        },
        {
            "endOffset": 24257,
            "parents": [],
            "refoffsets": {
                "b0105": {
                    "endOffset": 24147,
                    "startOffset": 24143
                }
            },
            "secId": "s0005",
            "sentence": "In conclusion, while therapies that target individual toxin domains or epitopes are efficacious [21], these data suggest that targeting multiple epitopes or domains have the potential for even greater efficacy.",
            "startOffset": 24047,
            "title": "Introduction"
        },
        {
            "endOffset": 27706,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Samples were loaded and run under reducing conditions at 1 \u03bcg/lane on 4\u201312% Bis-Tris gradient gels in 1\u00d7 MES running buffer with antioxidant, at 200 V for 40 min at RT.",
            "startOffset": 27538,
            "title": "SDS-PAGE and Western Blotting"
        },
        {
            "endOffset": 33742,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0060",
            "sentence": "Purified C. difficile toxinotype III TcdA and TcdB were purchased from tgcBIOMICS (Tcd-027, Bingen, Germany).",
            "startOffset": 33633,
            "title": "Vero cell-based C. difficile toxin neutralization assay"
        },
        {
            "endOffset": 41847,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "This overall ranking for the mAb combinations was confirmed in a stress version of the TEER assay.",
            "startOffset": 41749,
            "title": "Enhancement of neutralizing activity of human anti-TcdB mAbs to different toxin domains when used in combination"
        },
        {
            "endOffset": 27327,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "All SDS-PAGE and WB reagents were from the Thermo Fisher Scientific NU-PAGE Bis-Tris system.",
            "startOffset": 27235,
            "title": "SDS-PAGE and Western Blotting"
        },
        {
            "endOffset": 41013,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "29 pM.",
            "startOffset": 41007,
            "title": "Enhancement of neutralizing activity of human anti-TcdB mAbs to different toxin domains when used in combination"
        },
        {
            "endOffset": 33306,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0100": {
                    "endOffset": 33305,
                    "startOffset": 33301
                }
            },
            "secId": "s0060",
            "sentence": "The assay procedure was described in detail previously [20].",
            "startOffset": 33246,
            "title": "Vero cell-based C. difficile toxin neutralization assay"
        },
        {
            "endOffset": 40407,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0100": {
                    "endOffset": 40406,
                    "startOffset": 40402
                }
            },
            "secId": "s0080",
            "sentence": "We had previously shown that the combination of two mAbs to the GTD domain of TcdB (B1 and B2) provided improved in vitro toxin neutralizing potency and in vivo efficacy over individual mAbs [20].",
            "startOffset": 40211,
            "title": "Enhancement of neutralizing activity of human anti-TcdB mAbs to different toxin domains when used in combination"
        },
        {
            "endOffset": 47827,
            "parents": [],
            "secId": "s0100",
            "sentence": "In order to differentiate combinations of mAbs, \u201cstress\u201d versions of the Vero cell and TEER assays were used.",
            "startOffset": 47718,
            "title": "Discussion"
        },
        {
            "endOffset": 26678,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "The membrane was probed with the indicated mAbs at a concentration of 0.0215 \u03bcg/mL in blocking solution for 1 h at RT with agitation, or overnight at 4 \u00b0C without agitation.",
            "startOffset": 26505,
            "title": "Dot blotting"
        },
        {
            "endOffset": 41542,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "We first examined the impact of increasing number of mAbs targeting a single domain by creating cocktails of 5 GTD only mAbs (B1, B2, B9, B19, B20) or 5 CTD only mAbs (B6, B8, A14/B26, B12, B21).",
            "startOffset": 41347,
            "title": "Enhancement of neutralizing activity of human anti-TcdB mAbs to different toxin domains when used in combination"
        },
        {
            "endOffset": 39194,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "In contrast, the anti-TcdB mAbs bound more equivalently across the TcdB domains: 23% to GTD (B4 fragment), 19% to CPD + PFR (B1 fragment), 19% to TLD (B2 fragment) and 19% to CTD (CROP B1-B4 fragments).",
            "startOffset": 38992,
            "title": "Mapping of human C. difficile toxin neutralizing mAbs at toxin domain level"
        },
        {
            "endOffset": 39481,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "The toxin neutralizing activities of individual mAbs were assessed in the Vero cell cytotoxicity and the T84 cell transepithelial electrical resistance (TEER) assays using toxinotype 0 toxins.",
            "startOffset": 39289,
            "title": "Mapping of human C. difficile toxin neutralizing mAbs at toxin domain level"
        },
        {
            "endOffset": 39689,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "The activities for these mAbs ranged from 0 (no activity) to 100% (complete toxin neutralization).",
            "startOffset": 39591,
            "title": "Mapping of human C. difficile toxin neutralizing mAbs at toxin domain level"
        },
        {
            "endOffset": 22311,
            "parents": [],
            "refoffsets": {
                "b0015": {
                    "endOffset": 22310,
                    "startOffset": 22305
                },
                "b0020": {
                    "endOffset": 22310,
                    "startOffset": 22305
                },
                "b0025": {
                    "endOffset": 22310,
                    "startOffset": 22305
                }
            },
            "secId": "s0005",
            "sentence": "The different toxin domains function collaboratively to inactivate small guanosine triphosphatases which leads to actin cytoskeleton disruption, destruction of tight junctions, induction of pro-inflammatory responses, and death of intestinal tissue [3\u20135].",
            "startOffset": 22056,
            "title": "Introduction"
        },
        {
            "endOffset": 42649,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "The GTD-only mAbs cocktail fully protected against toxin concentrations of up to 4.3 pM, however, the addition of a single anti-CTD mAb increased the protective capacity up to 39.1 pM.",
            "startOffset": 42465,
            "title": "Enhancement of neutralizing activity of human anti-TcdB mAbs to different toxin domains when used in combination"
        },
        {
            "endOffset": 23430,
            "parents": [],
            "secId": "s0005",
            "sentence": "Noting the potential importance of targeting multiple toxin domains, we assessed the domain specificities of antibodies induced by immunization with a C. difficile toxoid vaccine candidate.",
            "startOffset": 23241,
            "title": "Introduction"
        },
        {
            "endOffset": 23890,
            "parents": [],
            "secId": "s0005",
            "sentence": "Immunoabsorption experiments using recombinant fragments revealed that GTD and CTD fragments were required to impede the serum antibody neutralization of TcdA while a combination of GTD, CTD and CPD + PFR fragments was necessary for the inhibition of TcdB neutralization.",
            "startOffset": 23619,
            "title": "Introduction"
        },
        {
            "endOffset": 34109,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0060",
            "sentence": "Even at the lowest concentrations of antibodies tested, there was at least 10-fold molar excess of antibodies over toxin.",
            "startOffset": 33988,
            "title": "Vero cell-based C. difficile toxin neutralization assay"
        },
        {
            "endOffset": 36056,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0060",
            "sentence": "Testing was performed in at least three separate experiments.",
            "startOffset": 35995,
            "title": "Vero cell-based C. difficile toxin neutralization assay"
        },
        {
            "endOffset": 21258,
            "parents": [],
            "secId": "s0005",
            "sentence": "Clostridium difficile is spore-forming toxin producing, Gram-positive anaerobic bacillus that when transmitted through the fecal\u2013oral route can cause of pseudomembranous colitis and infectious diarrhea.",
            "startOffset": 21056,
            "title": "Introduction"
        },
        {
            "endOffset": 33833,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0060",
            "sentence": "One MC50 dose for TcdA and TcdB of toxinotype III was 1.43 pM and 0.1137 pM, respectively.",
            "startOffset": 33743,
            "title": "Vero cell-based C. difficile toxin neutralization assay"
        },
        {
            "endOffset": 27537,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "C. difficile toxins and recombinant toxin fragments were prepared for analysis by diluting to a concentration of 1 \u03bcg/15 \u03bcl in 1\u00d7 LDS loading buffer and 1\u00d7 sample reducing agent and heating to 95 \u00b0C for 5 min.",
            "startOffset": 27328,
            "title": "SDS-PAGE and Western Blotting"
        },
        {
            "endOffset": 39928,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "While both assays measured the ability of antibody to neutralize the impact of toxin, the activities of different mAbs were not always aligned between the two assays suggesting that different mechanisms of toxin action are being assessed.",
            "startOffset": 39690,
            "title": "Mapping of human C. difficile toxin neutralizing mAbs at toxin domain level"
        },
        {
            "endOffset": 27995,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Proteins were visualized after SDS-PAGE by staining with Coomassie Brilliant Blue SimplyBlue safe stain (Thermo) used per the manufacturer\u2019s instructions.",
            "startOffset": 27841,
            "title": "SDS-PAGE and Western Blotting"
        },
        {
            "endOffset": 43390,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "However the addition of either the TLD-specific mAbs B5 or B7 or the CTD-specific mAb B6 greatly increased the neutralizing activity and the CPD + PFR mAb B24 as well as the TLD mAb B4 minimally increased the neutralizing activity of the new mAb combination (Fig. 4).",
            "startOffset": 43123,
            "title": "Enhancement of neutralizing activity of human anti-TcdB mAbs to different toxin domains when used in combination"
        },
        {
            "endOffset": 43122,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0100": {
                    "endOffset": 43089,
                    "startOffset": 43085
                }
            },
            "secId": "s0080",
            "sentence": "When assessed at 4.34 pM of TcdB in the Vero cell assay, the previously identified GTD-specific B1 + B2 mAb combination [20] showed no neutralizing activity.",
            "startOffset": 42965,
            "title": "Enhancement of neutralizing activity of human anti-TcdB mAbs to different toxin domains when used in combination"
        },
        {
            "endOffset": 36087,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0060",
            "sentence": "Intra-assay precision was 20%.",
            "startOffset": 36057,
            "title": "Vero cell-based C. difficile toxin neutralization assay"
        },
        {
            "endOffset": 37023,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0065",
            "sentence": "For testing of neutralizing activity of mAbs, TcdB was combined with antibody at a 1:1 ratio by volume and incubated at 37 \u00b0C for 30 min before 100 \u00b5l of mixture being added to polarized T84 cells.",
            "startOffset": 36826,
            "title": "Transepithelial electrical resistance C. difficile TcdB neutralization assay"
        },
        {
            "endOffset": 23240,
            "parents": [],
            "refoffsets": {
                "b0100": {
                    "endOffset": 23080,
                    "startOffset": 23076
                }
            },
            "secId": "s0005",
            "sentence": "While neutralization can be achieved by single mAb [20], combinations of mAbs that target multiple epitopes within a toxin domain or across multiple domains are able to neutralize far higher concentrations of toxin.",
            "startOffset": 23025,
            "title": "Introduction"
        },
        {
            "endOffset": 50219,
            "parents": [],
            "secId": "s0100",
            "sentence": "These data suggest that full understanding of the neutralizing activity of anti-toxin mAbs should include assessment both alone and in combination as it appears possible that the binding of one mAb could impact the confirmation of the toxin thereby impacting and perhaps even improving the binding of additional mAbs.",
            "startOffset": 49902,
            "title": "Discussion"
        },
        {
            "endOffset": 45509,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "An excess of recombinant toxin fragments was mixed with the immune sera to absorb all of the antibodies that bound to that domain thereby preventing those particular domain-specific antibodies from interacting with the toxin.",
            "startOffset": 45284,
            "title": "Inhibition of neutralizing activity of immune sera with C. difficile toxin recombinant fragments"
        },
        {
            "endOffset": 49666,
            "parents": [],
            "secId": "s0100",
            "sentence": "Interestingly the activity of the individual mAbs in the Vero cell neutralization assay (Table 3) was not fully predictive of the impact mAbs in combination of mAbs (Fig. 4) as neither mAb B4 nor B6 demonstrated activity in the Vero cell neutralization assay, yet the addition of the B6 to the two GTD specific mAbs B1 + B2 (Fig. 4) was far more impactful in terms of increasing the neutralizing activity than the addition of B4.",
            "startOffset": 49237,
            "title": "Discussion"
        },
        {
            "endOffset": 55204,
            "parents": [],
            "secId": "s0100",
            "sentence": "Taken together these data support a rationale for preventative or therapeutic C. difficile treatments that involve a polyclonal response against multiple toxin domains and that this multi domain targeting approach could be particularly impactful in ameliorating CDI cases involving high levels of toxin production.",
            "startOffset": 54890,
            "title": "Discussion"
        },
        {
            "endOffset": 22055,
            "parents": [],
            "secId": "s0005",
            "sentence": "Both toxins are composed of four separate functional domains listed in order from N- to C-terminus of the protein: a glucosyltransferase domain (GTD), a cysteine protease domain (CPD), a translocation domain (TLD), which includes a pore forming region (PFR), and a C-terminal domain (CTD) composed of multiple smaller subdomains called combined repetitive oligopeptides (CROPs).",
            "startOffset": 21677,
            "title": "Introduction"
        },
        {
            "endOffset": 46112,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "In contrast, only the combination of the GTD, CTD, and CPD + PFR, but not individual (GTD and CTD are shown) or combination of any two (GTD + CTD is shown) fragments of TcdB, were able to abrogate the neutralizing activity of vaccine candidate-induced sera against TcdB (Fig. 6).",
            "startOffset": 45833,
            "title": "Inhibition of neutralizing activity of immune sera with C. difficile toxin recombinant fragments"
        },
        {
            "endOffset": 48772,
            "parents": [],
            "secId": "s0100",
            "sentence": "While the toxin concentration in stool may not be equivalent to the concentration in the intestinal lumen, using concentrations of TcdB that fall within the range of or even exceed the values from stool samples from untreated CDI patients suggests that our in vitro assays involved clinically relevant concentrations.",
            "startOffset": 48455,
            "title": "Discussion"
        },
        {
            "endOffset": 30943,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0050",
            "sentence": "On day 41, 10 mg/kg of clindamycin-2-phosphate antibiotic solution was administered via the intraperitoneal route to disrupt the gut microbiota and render the animals susceptible to subsequent lethal challenge.",
            "startOffset": 30733,
            "title": "Generation of C. difficile toxoid vaccine candidate-induced sera in hamsters"
        },
        {
            "endOffset": 49901,
            "parents": [],
            "secId": "s0100",
            "sentence": "In contrast, B5, B7, and B24 all showed very potent neutralizing activity when tested individually in the Vero cell neutralization assay, but the mAbs B5 and B7 were far more impactful when tested in combination with B1 + B2 than B24.",
            "startOffset": 49667,
            "title": "Discussion"
        },
        {
            "endOffset": 22626,
            "parents": [],
            "refoffsets": {
                "b0030": {
                    "endOffset": 22503,
                    "startOffset": 22497
                },
                "b0035": {
                    "endOffset": 22503,
                    "startOffset": 22497
                },
                "b0040": {
                    "endOffset": 22503,
                    "startOffset": 22497
                },
                "b0045": {
                    "endOffset": 22503,
                    "startOffset": 22497
                },
                "b0050": {
                    "endOffset": 22503,
                    "startOffset": 22497
                },
                "b0055": {
                    "endOffset": 22503,
                    "startOffset": 22497
                },
                "b0060": {
                    "endOffset": 22503,
                    "startOffset": 22497
                },
                "b0065": {
                    "endOffset": 22503,
                    "startOffset": 22497
                },
                "b0070": {
                    "endOffset": 22524,
                    "startOffset": 22517
                },
                "b0075": {
                    "endOffset": 22524,
                    "startOffset": 22517
                },
                "b0080": {
                    "endOffset": 22524,
                    "startOffset": 22517
                },
                "b0085": {
                    "endOffset": 22524,
                    "startOffset": 22517
                },
                "b0090": {
                    "endOffset": 22524,
                    "startOffset": 22517
                },
                "b0095": {
                    "endOffset": 22524,
                    "startOffset": 22517
                }
            },
            "secId": "s0005",
            "sentence": "While evidence for importance of antibody mediated toxin A and toxin B neutralization in protection against CDI associated symptomatic disease has been demonstrated in both preclinical [6\u201313] and clinical [14\u201319] studies, less is known about the specific epitopes associated with this antibody mediated protection.",
            "startOffset": 22312,
            "title": "Introduction"
        },
        {
            "endOffset": 28491,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "The membrane was washed 3\u00d7 for 5 min with PBST at RT with agitation prior to incubation with the appropriate secondary antibody (goat anti-human IgG, alkaline phosphatase-labeled) diluted 1:1000 in PBST.",
            "startOffset": 28288,
            "title": "SDS-PAGE and Western Blotting"
        },
        {
            "endOffset": 46686,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0095",
            "sentence": "We next tested these polyclonal sera in the toxin neutralization \u201cstress\u201d test.",
            "startOffset": 46607,
            "title": "High neutralizing potency of vaccine candidate-induced polyclonal sera against elevated concentrations of both C. difficile toxins"
        },
        {
            "endOffset": 53522,
            "parents": [],
            "refoffsets": {
                "b0155": {
                    "endOffset": 53521,
                    "startOffset": 53517
                }
            },
            "secId": "s0100",
            "sentence": "In contrast, TcdB binding to PVRL3 is independent of the CROP domain [31].",
            "startOffset": 53448,
            "title": "Discussion"
        },
        {
            "endOffset": 54127,
            "parents": [],
            "secId": "s0100",
            "sentence": "Therefore one way antibodies to multiple domains could be impacting toxin activity is by blocking these multiple paths of toxin association to the cell surface.",
            "startOffset": 53967,
            "title": "Discussion"
        },
        {
            "endOffset": 54414,
            "parents": [],
            "secId": "s0100",
            "sentence": "In conclusion, this work has extended knowledge about the domain specificity of toxin neutralizing antibodies.",
            "startOffset": 54304,
            "title": "Discussion"
        },
        {
            "endOffset": 47226,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0095",
            "sentence": "These data suggest that a mixture of polyclonal antibodies against multiple toxin domains possess higher gram-to-gram potency than a mAb against a single domain.",
            "startOffset": 47065,
            "title": "High neutralizing potency of vaccine candidate-induced polyclonal sera against elevated concentrations of both C. difficile toxins"
        },
        {
            "endOffset": 25977,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                },
                {
                    "id": "s0015",
                    "title": "Recombinant C. difficile toxin fragment preparation"
                }
            ],
            "secId": "s0025",
            "sentence": "Purity was assessed at 95% by densitometry of the Coomassie-stained SDS-PAGE gels.",
            "startOffset": 25895,
            "title": "Cloning, expression, and purification of the MLD and ASE fragments of TcdB"
        },
        {
            "endOffset": 35624,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0060",
            "sentence": "The plates were mixed and incubated at 37 \u00b0C for 4 h before reading fluorescence at 560 to 590 nm with a cutoff at 590 nm.",
            "startOffset": 35502,
            "title": "Vero cell-based C. difficile toxin neutralization assay"
        },
        {
            "endOffset": 32588,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0055",
            "sentence": "After overnight incubation and washing blocking buffer containing 1% BSA was added to each well of the plate for 1 h at 37 \u00b0C.",
            "startOffset": 32462,
            "title": "Indirect ELISA with recombinant toxin domain fragments"
        },
        {
            "endOffset": 41179,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "In the \u201cstress\u201d TEER assay both the toxin concentration (0.83 nM) and time of exposure (5 h) were increased over what was used for the assessment of individual mAbs.",
            "startOffset": 41014,
            "title": "Enhancement of neutralizing activity of human anti-TcdB mAbs to different toxin domains when used in combination"
        },
        {
            "endOffset": 51029,
            "parents": [],
            "refoffsets": {
                "b0100": {
                    "endOffset": 50915,
                    "startOffset": 50911
                },
                "b0120": {
                    "endOffset": 51028,
                    "startOffset": 51024
                }
            },
            "secId": "s0100",
            "sentence": "A2, the most potent anti-TcdA mAb we had previously identified, binds multiple A/VTGWQTI sites within the CTD [20] and the toxin neutralizing mAb actoxumab binds to two distinct sites in the in the CROPs of the CTD of TcdA [24].",
            "startOffset": 50801,
            "title": "Discussion"
        },
        {
            "endOffset": 24897,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                },
                {
                    "id": "s0015",
                    "title": "Recombinant C. difficile toxin fragment preparation"
                }
            ],
            "secId": "s0020",
            "sentence": "Additional constructs used in the mapping studies were cloned and prepared in the procedures outlined below.",
            "startOffset": 24789,
            "title": "Generation of domain mapping reagents"
        },
        {
            "endOffset": 24788,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                },
                {
                    "id": "s0015",
                    "title": "Recombinant C. difficile toxin fragment preparation"
                }
            ],
            "refoffsets": {
                "b0040": {
                    "endOffset": 24787,
                    "startOffset": 24784
                }
            },
            "secId": "s0020",
            "sentence": "Fragments designated B1, B2, B4 were defined by Kink and Williams [8].",
            "startOffset": 24718,
            "title": "Generation of domain mapping reagents"
        },
        {
            "endOffset": 33574,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0060",
            "sentence": "Purified C. difficile toxinotype 0 TcdA and TcdB used in the assay were produced in-house from the reference strain VPI 10463 (ATCC 43255) as per internal procedures.",
            "startOffset": 33408,
            "title": "Vero cell-based C. difficile toxin neutralization assay"
        },
        {
            "endOffset": 52523,
            "parents": [],
            "secId": "s0100",
            "sentence": "While we identified toxin neutralizing human mAbs specific to the TLD of TcdB, the results of the immunoabsorption experiment indicated that anti-TLD neutralizing antibodies were not detected in the serum of hamsters immunized with a toxoid vaccine candidate.",
            "startOffset": 52264,
            "title": "Discussion"
        },
        {
            "endOffset": 37256,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0065",
            "sentence": "A final concentration of 0.83 nM TcdB of toxinotype 0 was used for the challenge dose and was equivalent to 15 xTEER50.",
            "startOffset": 37137,
            "title": "Transepithelial electrical resistance C. difficile TcdB neutralization assay"
        },
        {
            "endOffset": 25459,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                },
                {
                    "id": "s0015",
                    "title": "Recombinant C. difficile toxin fragment preparation"
                }
            ],
            "secId": "s0025",
            "sentence": "Recombinant expression was induced in LB medium using 1 mM IPTG.",
            "startOffset": 25395,
            "title": "Cloning, expression, and purification of the MLD and ASE fragments of TcdB"
        },
        {
            "endOffset": 32237,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0055",
            "sentence": "Levels of the IgG specific to any given recombinant toxin fragment were normalized to the total IgG titers bound to the respective full length toxin, which was considered 100%.",
            "startOffset": 32061,
            "title": "Indirect ELISA with recombinant toxin domain fragments"
        },
        {
            "endOffset": 28957,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Sensors coated with Protein A were first wet for 10 min in Fort\u00e9Bio kinetics buffer (KB), PBS pH 7.4 containing 0.002% Tween-20 and 0.1 mg/ml bovine serum albumin (BSA).",
            "startOffset": 28788,
            "title": "Fort\u00e9bio Octet assessments"
        },
        {
            "endOffset": 50504,
            "parents": [],
            "secId": "s0100",
            "sentence": "These mAb combining experiments used only TcdB as the majority of the identified TcdA mAbs were specific for a single domain, CTD (Table 2) and the two TLD mAbs and one GTD mAb showed no activity in the Vero cell cytotoxicity assay and weak activity in the TEER assay (data not shown).",
            "startOffset": 50219,
            "title": "Discussion"
        },
        {
            "endOffset": 43533,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "The differential impact of the TLD mAbs B4, B5 and B7 suggests that the impact on neutralizing activity is epitope as well as domain specific.",
            "startOffset": 43391,
            "title": "Enhancement of neutralizing activity of human anti-TcdB mAbs to different toxin domains when used in combination"
        },
        {
            "endOffset": 31827,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0055",
            "sentence": "Mapping of the antibody-binding epitopes within candidate vaccine-induced sera was performed by indirect ELISA using the following recombinant C. difficile toxin fragments: GTD and CTD of TcdA and B4 (GTD), B1 (CPD + PFR), B2 (TLD), and CROP B1 (CTD) of TcdB (Table 1).",
            "startOffset": 31558,
            "title": "Indirect ELISA with recombinant toxin domain fragments"
        },
        {
            "endOffset": 30732,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0050",
            "sentence": "Animals were bled and sera were collected on day 35.",
            "startOffset": 30680,
            "title": "Generation of C. difficile toxoid vaccine candidate-induced sera in hamsters"
        },
        {
            "endOffset": 54889,
            "parents": [],
            "secId": "s0100",
            "sentence": "We also demonstrated that increasing the domain coverage enables neutralization of higher concentrations of toxin.",
            "startOffset": 54775,
            "title": "Discussion"
        },
        {
            "endOffset": 49061,
            "parents": [],
            "secId": "s0100",
            "sentence": "The activity of a multi-domain combination was much greater than an equivalent concentration of individual mAbs or a combination of mAbs to two toxin domains.",
            "startOffset": 48903,
            "title": "Discussion"
        },
        {
            "endOffset": 53311,
            "parents": [],
            "secId": "s0100",
            "sentence": "TcdB binds to the cell surface receptor chondroitin sulfate proteoglycan 4 (CSPG4) at the junction between the translocation and CROP domains and binding involves the first three oligopeptide repeats of this CROP domain.",
            "startOffset": 53091,
            "title": "Discussion"
        }
    ],
    "docId": "S0264410X19306644",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": null,
                "first": "Leah E.",
                "initial": "L.E.",
                "last": "Cole"
            },
            {
                "email": null,
                "first": "Lu",
                "initial": "L.",
                "last": "Li"
            },
            {
                "email": null,
                "first": "Utsav",
                "initial": "U.",
                "last": "Jetley"
            },
            {
                "email": null,
                "first": "Jinrong",
                "initial": "J.",
                "last": "Zhang"
            },
            {
                "email": null,
                "first": "Kristl",
                "initial": "K.",
                "last": "Pacheco"
            },
            {
                "email": null,
                "first": "Fuqin",
                "initial": "F.",
                "last": "Ma"
            },
            {
                "email": null,
                "first": "Jianxin",
                "initial": "J.",
                "last": "Zhang"
            },
            {
                "email": null,
                "first": "Sophia",
                "initial": "S.",
                "last": "Mundle"
            },
            {
                "email": null,
                "first": "Yanhua",
                "initial": "Y.",
                "last": "Yan"
            },
            {
                "email": null,
                "first": "Lucianna",
                "initial": "L.",
                "last": "Barone"
            },
            {
                "email": null,
                "first": "Christopher",
                "initial": "C.",
                "last": "Rogers"
            },
            {
                "email": null,
                "first": "Nicola",
                "initial": "N.",
                "last": "Beltraminelli"
            },
            {
                "email": null,
                "first": "Laurence",
                "initial": "L.",
                "last": "Quemeneur"
            },
            {
                "email": null,
                "first": "Harry",
                "initial": "H.",
                "last": "Kleanthous"
            },
            {
                "email": null,
                "first": "Stephen F.",
                "initial": "S.F.",
                "last": "Anderson"
            },
            {
                "email": "natalie.anosova@sanofi.com",
                "first": "Natalie G.",
                "initial": "N.G.",
                "last": "Anosova"
            }
        ],
        "doi": "10.1016/j.vaccine.2019.05.040",
        "firstpage": "3892",
        "issn": "0264410X",
        "keywords": [
            "Antibody",
            "C. difficile",
            "Neutralizing",
            "Toxoid",
            "Vaccine"
        ],
        "lastpage": "3901",
        "openaccess": "Full",
        "pub_year": 2019,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Deciphering the domain specificity of C. difficile toxin neutralizing antibodies"
    }
}